{"transactions":[{"id":773867,"issuer":{"id":3953,"kind":"organization","name":"HAEMONETICS CORP"},"owners":[{"id":46227,"kind":"person","name":"Basil Michelle L","position":1,"cik":"0001699629","reported_name":"Basil Michelle L","relationship":{"officer":true,"officer_title":"EVP and General Counsel"}}],"security":"Common Stock","published_at":"2026-05-19T21:37:56.000Z","date":"2026-05-15","kind":"grant","planned":false,"acquired":true,"shares":28424,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F3","text":"The securities awarded are in the form of RSUs issued pursuant to the Haemonetics Corporation Amended and Restated 2019 Long-Term Incentive Compensation Plan. The RSUs vest in three annual installments with forty percent of the total award vesting on the first anniversary of the date of grant, forty percent vesting on the second anniversary of the date of grant and the remaining twenty percent vesting on the third anniversary of the date of grant."},{"field":"price","element":"transactionPricePerShare","label":"F4","text":"Each RSU represents a contingent right to receive one (1) share of the Issuer's common stock when vested."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"This number includes unvested RSUs previously reported."}],"balance_after":68829,"source":{"system":"sec-edgar","filing":"0000313143-26-000048","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/313143/000031314326000048/form4.xml","form_type":"4"}},{"id":773866,"issuer":{"id":3953,"kind":"organization","name":"HAEMONETICS CORP"},"owners":[{"id":46227,"kind":"person","name":"Basil Michelle L","position":1,"cik":"0001699629","reported_name":"Basil Michelle L","relationship":{"officer":true,"officer_title":"EVP and General Counsel"}}],"security":"Common Stock","published_at":"2026-05-19T21:37:56.000Z","date":"2026-05-15","kind":"tax_withholding","planned":false,"acquired":false,"shares":2913,"price":56.29,"value":163972.77,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents shares withheld for tax obligations in connection with the vesting of certain restricted stock units (\"RSUs\") previously reported in Table I."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"This number includes unvested RSUs previously reported."}],"balance_after":40405,"source":{"system":"sec-edgar","filing":"0000313143-26-000048","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/313143/000031314326000048/form4.xml","form_type":"4"}},{"id":1112688,"issuer":{"id":3953,"kind":"organization","name":"HAEMONETICS CORP"},"owners":[{"id":46227,"kind":"person","name":"Basil Michelle L","position":1,"cik":"0001699629","reported_name":"Basil Michelle L","relationship":{"officer":true,"officer_title":"EVP and General Counsel"}}],"security":"Non-qualified Stock Option (Right to Buy)","published_at":"2025-06-13T20:26:00.000Z","date":"2025-05-16","kind":"grant","planned":false,"acquired":true,"shares":14626,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F5","text":"On May 20, 2025, the reporting person filed a Form 4 that incorrectly showed the amount of options awarded to be 12,317 instead of 14,626.  This net increase of 2,309 options will be reflected in future filings by the reporting person."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F6","text":"Option vests in annual increments of 25% beginning on the first anniversary of the date of grant."}],"balance_after":14626,"derivative":{"exercise_price":70.31,"expiration_date":"2032-05-16","underlying":"Common Stock","underlying_shares":14626},"source":{"system":"sec-edgar","filing":"0001127602-25-017498","document":"form4a.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/313143/000112760225017498/form4a.xml","form_type":"4/A","original_submission_date":"2025-05-20"}},{"id":1112687,"issuer":{"id":3953,"kind":"organization","name":"HAEMONETICS CORP"},"owners":[{"id":46227,"kind":"person","name":"Basil Michelle L","position":1,"cik":"0001699629","reported_name":"Basil Michelle L","relationship":{"officer":true,"officer_title":"EVP and General Counsel"}}],"security":"Common Stock","published_at":"2025-06-13T20:26:00.000Z","date":"2025-05-16","kind":"grant","planned":false,"acquired":true,"shares":6755,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"The securities awarded are in the form of restricted stock units (\"RSUs\") issued pursuant to the Haemonetics Corporation Amended and Restated 2019 Long-Term Incentive Compensation Plan. The RSUs vest in three equal annual installments beginning on the first anniversary of the date of grant."},{"field":"shares","element":"transactionShares","label":"F2","text":"On May 20, 2025, the reporting person filed a Form 4 that incorrectly showed the amount of RSUs awarded to be 5,689 instead of 6,755.  This net increase of 1,066 RSUs, and the corresponding change in securities beneficially owned by the reporting person, will be reflected in future filings by the reporting person."},{"field":"price","element":"transactionPricePerShare","label":"F3","text":"Each RSU represents a contingent right to receive one (1) share of the Issuer's common stock when vested."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F4","text":"This number includes unvested RSUs previously reported."}],"balance_after":35233,"source":{"system":"sec-edgar","filing":"0001127602-25-017498","document":"form4a.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/313143/000112760225017498/form4a.xml","form_type":"4/A","original_submission_date":"2025-05-20"}},{"id":1126648,"issuer":{"id":3953,"kind":"organization","name":"HAEMONETICS CORP"},"owners":[{"id":46227,"kind":"person","name":"Basil Michelle L","position":1,"cik":"0001699629","reported_name":"Basil Michelle L","relationship":{"officer":true,"officer_title":"EVP and General Counsel"}}],"security":"Common Stock","published_at":"2025-06-03T20:31:04.000Z","date":"2025-05-30","kind":"tax_withholding","planned":false,"acquired":false,"shares":7469,"price":69.38,"value":518199.22,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F3","text":"Represents shares withheld for tax obligations in connection with the vesting of certain PSUs reported in Table I."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"This number includes unvested restricted stock units (\"RSUs\") previously reported."}],"balance_after":42252,"source":{"system":"sec-edgar","filing":"0001127602-25-016497","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/313143/000112760225016497/form4.xml","form_type":"4"}},{"id":1126647,"issuer":{"id":3953,"kind":"organization","name":"HAEMONETICS CORP"},"owners":[{"id":46227,"kind":"person","name":"Basil Michelle L","position":1,"cik":"0001699629","reported_name":"Basil Michelle L","relationship":{"officer":true,"officer_title":"EVP and General Counsel"}}],"security":"Common Stock","published_at":"2025-06-03T20:31:04.000Z","date":"2025-05-30","kind":"grant","planned":false,"acquired":true,"shares":15554,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents shares earned from a performance share unit (\"PSU\") award granted to the reporting person on May 16, 2022, based on the issuer's total shareholder return relative to that of the companies comprising the S&P MidCap 400 Index for the performance period from May 16, 2022 to May 15, 2025, as certified by the Compensation Committee of the Board of Directors on May 30, 2025."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"This number includes unvested restricted stock units (\"RSUs\") previously reported."}],"balance_after":49721,"source":{"system":"sec-edgar","filing":"0001127602-25-016497","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/313143/000112760225016497/form4.xml","form_type":"4"}},{"id":1141352,"issuer":{"id":3953,"kind":"organization","name":"HAEMONETICS CORP"},"owners":[{"id":46227,"kind":"person","name":"Basil Michelle L","position":1,"cik":"0001699629","reported_name":"Basil Michelle L","relationship":{"officer":true,"officer_title":"EVP and General Counsel"}}],"security":"Non-qualified Stock Option (Right to Buy)","published_at":"2025-05-20T21:17:48.000Z","date":"2025-05-16","kind":"grant","planned":false,"acquired":true,"shares":12317,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F4","text":"Option vests in annual increments of 25% beginning on the first anniversary of the date of grant."}],"balance_after":12317,"derivative":{"exercise_price":70.31,"expiration_date":"2032-05-16","underlying":"Common Stock","underlying_shares":12317},"source":{"system":"sec-edgar","filing":"0001127602-25-015058","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/313143/000112760225015058/form4.xml","form_type":"4"}},{"id":1141351,"issuer":{"id":3953,"kind":"organization","name":"HAEMONETICS CORP"},"owners":[{"id":46227,"kind":"person","name":"Basil Michelle L","position":1,"cik":"0001699629","reported_name":"Basil Michelle L","relationship":{"officer":true,"officer_title":"EVP and General Counsel"}}],"security":"Common Stock","published_at":"2025-05-20T21:17:48.000Z","date":"2025-05-16","kind":"grant","planned":false,"acquired":true,"shares":5689,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"The securities awarded are in the form of restricted stock units (\"RSUs\") issued pursuant to the Haemonetics Corporation Amended and Restated 2019 Long-Term Incentive Compensation Plan. The RSUs vest in three equal annual installments beginning on the first anniversary of the date of grant."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"Each RSU represents a contingent right to receive one (1) share of the Issuer's common stock when vested."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F3","text":"This number includes unvested RSUs previously reported."}],"balance_after":34167,"source":{"system":"sec-edgar","filing":"0001127602-25-015058","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/313143/000112760225015058/form4.xml","form_type":"4"}},{"id":1144265,"issuer":{"id":3953,"kind":"organization","name":"HAEMONETICS CORP"},"owners":[{"id":46227,"kind":"person","name":"Basil Michelle L","position":1,"cik":"0001699629","reported_name":"Basil Michelle L","relationship":{"officer":true,"officer_title":"EVP and General Counsel"}}],"security":"Common Stock","published_at":"2025-05-19T21:17:24.000Z","date":"2025-05-16","kind":"tax_withholding","planned":false,"acquired":false,"shares":2157,"price":70.31,"value":151658.67,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents shares withheld for tax obligations in connection with the vesting of certain restricted stock units (\"RSUs\") previously reported in Table I."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"This number includes unvested RSUs previously reported."}],"balance_after":28478,"source":{"system":"sec-edgar","filing":"0001127602-25-014945","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/313143/000112760225014945/form4.xml","form_type":"4"}},{"id":1144264,"issuer":{"id":3953,"kind":"organization","name":"HAEMONETICS CORP"},"owners":[{"id":46227,"kind":"person","name":"Basil Michelle L","position":1,"cik":"0001699629","reported_name":"Basil Michelle L","relationship":{"officer":true,"officer_title":"EVP and General Counsel"}}],"security":"Common Stock","published_at":"2025-05-19T21:17:24.000Z","date":"2025-05-15","kind":"tax_withholding","planned":false,"acquired":false,"shares":622,"price":69.38,"value":43154.36,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents shares withheld for tax obligations in connection with the vesting of certain restricted stock units (\"RSUs\") previously reported in Table I."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"This number includes unvested RSUs previously reported."}],"balance_after":30635,"source":{"system":"sec-edgar","filing":"0001127602-25-014945","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/313143/000112760225014945/form4.xml","form_type":"4"}},{"id":1499734,"issuer":{"id":3953,"kind":"organization","name":"HAEMONETICS CORP"},"owners":[{"id":46227,"kind":"person","name":"Basil Michelle L","position":1,"cik":"0001699629","reported_name":"Basil Michelle L","relationship":{"officer":true,"officer_title":"EVP and General Counsel"}}],"security":"Common Stock","published_at":"2024-05-29T21:38:39.000Z","date":"2024-05-29","kind":"sale","planned":true,"acquired":false,"shares":4094,"price":88.57,"value":362605.58,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F4","text":"Transaction pursuant to an existing 10b5-1 trading plan dated December 13, 2023 (fully executed as of December 14, 2023)."},{"field":"price","element":"transactionPricePerShare","label":"F6","text":"The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $88.29 to $88.92, inclusive."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"This number includes unvested restricted stock units (\"RSUs\") previously reported."}],"balance_after":31257,"source":{"system":"sec-edgar","filing":"0001127602-24-016810","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/313143/000112760224016810/form4.xml","form_type":"4"}},{"id":1499733,"issuer":{"id":3953,"kind":"organization","name":"HAEMONETICS CORP"},"owners":[{"id":46227,"kind":"person","name":"Basil Michelle L","position":1,"cik":"0001699629","reported_name":"Basil Michelle L","relationship":{"officer":true,"officer_title":"EVP and General Counsel"}}],"security":"Common Stock","published_at":"2024-05-29T21:38:39.000Z","date":"2024-05-29","kind":"sale","planned":true,"acquired":false,"shares":8896,"price":87.86,"value":781602.56,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F4","text":"Transaction pursuant to an existing 10b5-1 trading plan dated December 13, 2023 (fully executed as of December 14, 2023)."},{"field":"price","element":"transactionPricePerShare","label":"F5","text":"The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $87.28 to $88.28, inclusive. The reporting person undertakes to provide to Haemonetics Corporation (\"Haemonetics\"), any security holder of Haemonetics, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in footnotes (5) and (6) to this Form 4."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"This number includes unvested restricted stock units (\"RSUs\") previously reported."}],"balance_after":35351,"source":{"system":"sec-edgar","filing":"0001127602-24-016810","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/313143/000112760224016810/form4.xml","form_type":"4"}},{"id":1499732,"issuer":{"id":3953,"kind":"organization","name":"HAEMONETICS CORP"},"owners":[{"id":46227,"kind":"person","name":"Basil Michelle L","position":1,"cik":"0001699629","reported_name":"Basil Michelle L","relationship":{"officer":true,"officer_title":"EVP and General Counsel"}}],"security":"Common Stock","published_at":"2024-05-29T21:38:39.000Z","date":"2024-05-28","kind":"tax_withholding","planned":true,"acquired":false,"shares":11758,"price":95.73,"value":1125593.34,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F3","text":"Represents shares withheld for tax obligations in connection with the vesting of certain PSUs reported in Table I."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"This number includes unvested restricted stock units (\"RSUs\") previously reported."}],"balance_after":44247,"source":{"system":"sec-edgar","filing":"0001127602-24-016810","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/313143/000112760224016810/form4.xml","form_type":"4"}},{"id":1499731,"issuer":{"id":3953,"kind":"organization","name":"HAEMONETICS CORP"},"owners":[{"id":46227,"kind":"person","name":"Basil Michelle L","position":1,"cik":"0001699629","reported_name":"Basil Michelle L","relationship":{"officer":true,"officer_title":"EVP and General Counsel"}}],"security":"Common Stock","published_at":"2024-05-29T21:38:39.000Z","date":"2024-05-28","kind":"grant","planned":true,"acquired":true,"shares":24748,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents shares earned from a performance share unit (\"PSU\") award granted to the reporting person on May 18, 2021, based on the issuer's total shareholder return relative to that of the companies comprising the S&P MidCap 400 Index for the performance period from May 18, 2021 to May 17, 2024, as certified by the Compensation Committee of the Board of Directors on May 26, 2024."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"This number includes unvested restricted stock units (\"RSUs\") previously reported."}],"balance_after":56005,"source":{"system":"sec-edgar","filing":"0001127602-24-016810","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/313143/000112760224016810/form4.xml","form_type":"4"}},{"id":1508134,"issuer":{"id":3953,"kind":"organization","name":"HAEMONETICS CORP"},"owners":[{"id":46227,"kind":"person","name":"Basil Michelle L","position":1,"cik":"0001699629","reported_name":"Basil Michelle L","relationship":{"officer":true,"officer_title":"EVP and General Counsel"}}],"security":"Non-qualified Stock Option (Right to Buy)","published_at":"2024-05-21T21:46:36.000Z","date":"2024-05-17","kind":"grant","planned":true,"acquired":true,"shares":9183,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F6","text":"Option vests in annual increments of 25% beginning on the first anniversary of the date of grant."}],"balance_after":9183,"derivative":{"exercise_price":95.73,"expiration_date":"2031-05-17","underlying":"Common Stock","underlying_shares":9183},"source":{"system":"sec-edgar","filing":"0001127602-24-016164","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/313143/000112760224016164/form4.xml","form_type":"4"}},{"id":1508133,"issuer":{"id":3953,"kind":"organization","name":"HAEMONETICS CORP"},"owners":[{"id":46227,"kind":"person","name":"Basil Michelle L","position":1,"cik":"0001699629","reported_name":"Basil Michelle L","relationship":{"officer":true,"officer_title":"EVP and General Counsel"}}],"security":"Common Stock","published_at":"2024-05-21T21:46:36.000Z","date":"2024-05-20","kind":"sale","planned":true,"acquired":false,"shares":1604,"price":95.08,"value":152508.32,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Transaction pursuant to an existing 10b5-1 trading plan dated December 13, 2023 (fully executed as of December 14, 2023)."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"This number includes unvested restricted stock units (\"RSUs\") previously reported."}],"balance_after":31257,"source":{"system":"sec-edgar","filing":"0001127602-24-016164","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/313143/000112760224016164/form4.xml","form_type":"4"}},{"id":1508132,"issuer":{"id":3953,"kind":"organization","name":"HAEMONETICS CORP"},"owners":[{"id":46227,"kind":"person","name":"Basil Michelle L","position":1,"cik":"0001699629","reported_name":"Basil Michelle L","relationship":{"officer":true,"officer_title":"EVP and General Counsel"}}],"security":"Common Stock","published_at":"2024-05-21T21:46:36.000Z","date":"2024-05-17","kind":"grant","planned":true,"acquired":true,"shares":4178,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F4","text":"The securities awarded are in the form of RSUs issued pursuant to the Haemonetics Corporation Amended and Restated 2019 Long-Term Incentive Compensation Plan. The RSUs vest in three equal annual installments beginning on the first anniversary of the date of grant."},{"field":"price","element":"transactionPricePerShare","label":"F5","text":"Each RSU represents a contingent right to receive one (1) share of the Issuer's common stock when vested."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"This number includes unvested restricted stock units (\"RSUs\") previously reported."}],"balance_after":32861,"source":{"system":"sec-edgar","filing":"0001127602-24-016164","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/313143/000112760224016164/form4.xml","form_type":"4"}},{"id":1508131,"issuer":{"id":3953,"kind":"organization","name":"HAEMONETICS CORP"},"owners":[{"id":46227,"kind":"person","name":"Basil Michelle L","position":1,"cik":"0001699629","reported_name":"Basil Michelle L","relationship":{"officer":true,"officer_title":"EVP and General Counsel"}}],"security":"Common Stock","published_at":"2024-05-21T21:46:36.000Z","date":"2024-05-17","kind":"tax_withholding","planned":true,"acquired":false,"shares":669,"price":95.73,"value":64043.37,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F3","text":"Represents shares withheld for tax obligations in connection with the vesting of certain RSUs previously reported in Table I."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"This number includes unvested restricted stock units (\"RSUs\") previously reported."}],"balance_after":28683,"source":{"system":"sec-edgar","filing":"0001127602-24-016164","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/313143/000112760224016164/form4.xml","form_type":"4"}},{"id":1508130,"issuer":{"id":3953,"kind":"organization","name":"HAEMONETICS CORP"},"owners":[{"id":46227,"kind":"person","name":"Basil Michelle L","position":1,"cik":"0001699629","reported_name":"Basil Michelle L","relationship":{"officer":true,"officer_title":"EVP and General Counsel"}}],"security":"Common Stock","published_at":"2024-05-21T21:46:36.000Z","date":"2024-05-17","kind":"sale","planned":true,"acquired":false,"shares":1073,"price":95,"value":101935.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Transaction pursuant to an existing 10b5-1 trading plan dated December 13, 2023 (fully executed as of December 14, 2023)."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"This number includes unvested restricted stock units (\"RSUs\") previously reported."}],"balance_after":29352,"source":{"system":"sec-edgar","filing":"0001127602-24-016164","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/313143/000112760224016164/form4.xml","form_type":"4"}},{"id":1513273,"issuer":{"id":3953,"kind":"organization","name":"HAEMONETICS CORP"},"owners":[{"id":46227,"kind":"person","name":"Basil Michelle L","position":1,"cik":"0001699629","reported_name":"Basil Michelle L","relationship":{"officer":true,"officer_title":"EVP and General Counsel"}}],"security":"Common Stock","published_at":"2024-05-17T21:02:15.000Z","date":"2024-05-16","kind":"sale","planned":true,"acquired":false,"shares":985,"price":96.14,"value":94697.9,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F3","text":"Transaction pursuant to an existing 10b5-1 trading plan dated December 13, 2023 (fully executed as of December 14, 2023)."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"This number includes unvested RSUs previously reported."}],"balance_after":30425,"source":{"system":"sec-edgar","filing":"0001127602-24-015872","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/313143/000112760224015872/form4.xml","form_type":"4"}},{"id":1513272,"issuer":{"id":3953,"kind":"organization","name":"HAEMONETICS CORP"},"owners":[{"id":46227,"kind":"person","name":"Basil Michelle L","position":1,"cik":"0001699629","reported_name":"Basil Michelle L","relationship":{"officer":true,"officer_title":"EVP and General Counsel"}}],"security":"Common Stock","published_at":"2024-05-17T21:02:15.000Z","date":"2024-05-16","kind":"tax_withholding","planned":true,"acquired":false,"shares":446,"price":94.8,"value":42280.8,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents shares withheld for tax obligations in connection with the vesting of certain restricted stock units (\"RSUs\") previously reported in Table I."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"This number includes unvested RSUs previously reported."}],"balance_after":31410,"source":{"system":"sec-edgar","filing":"0001127602-24-015872","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/313143/000112760224015872/form4.xml","form_type":"4"}},{"id":1513271,"issuer":{"id":3953,"kind":"organization","name":"HAEMONETICS CORP"},"owners":[{"id":46227,"kind":"person","name":"Basil Michelle L","position":1,"cik":"0001699629","reported_name":"Basil Michelle L","relationship":{"officer":true,"officer_title":"EVP and General Counsel"}}],"security":"Common Stock","published_at":"2024-05-17T21:02:15.000Z","date":"2024-05-15","kind":"tax_withholding","planned":true,"acquired":false,"shares":416,"price":96.49,"value":40139.84,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents shares withheld for tax obligations in connection with the vesting of certain restricted stock units (\"RSUs\") previously reported in Table I."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"This number includes unvested RSUs previously reported."}],"balance_after":31856,"source":{"system":"sec-edgar","filing":"0001127602-24-015872","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/313143/000112760224015872/form4.xml","form_type":"4"}},{"id":1756037,"issuer":{"id":3953,"kind":"organization","name":"HAEMONETICS CORP"},"owners":[{"id":46227,"kind":"person","name":"Basil Michelle L","position":1,"cik":"0001699629","reported_name":"Basil Michelle L","relationship":{"officer":true,"officer_title":"EVP and General Counsel"}}],"security":"Common Stock","published_at":"2023-10-24T20:27:01.000Z","date":"2023-10-20","kind":"tax_withholding","planned":false,"acquired":false,"shares":197,"price":89.05,"value":17542.85,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents shares withheld for tax obligations in connection with the vesting of certain restricted stock units (\"RSUs\") previously reported in Table I."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"This number includes unvested RSUs previously reported."}],"balance_after":32272,"source":{"system":"sec-edgar","filing":"0001127602-23-026198","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/313143/000112760223026198/form4.xml","form_type":"4"}},{"id":1886126,"issuer":{"id":3953,"kind":"organization","name":"HAEMONETICS CORP"},"owners":[{"id":46227,"kind":"person","name":"Basil Michelle L","position":1,"cik":"0001699629","reported_name":"Basil Michelle L","relationship":{"officer":true,"officer_title":"EVP and General Counsel"}}],"security":"Common Stock","published_at":"2023-05-19T20:37:31.000Z","date":"2023-05-18","kind":"tax_withholding","planned":false,"acquired":false,"shares":3541,"price":83.34,"value":295106.94,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents shares withheld for tax obligations in connection with the vesting of certain restricted stock units (\"RSUs\") previously reported in Table I."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"This number includes unvested RSUs previously reported."}],"balance_after":32469,"source":{"system":"sec-edgar","filing":"0001127602-23-016315","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/313143/000112760223016315/form4.xml","form_type":"4"}},{"id":1890594,"issuer":{"id":3953,"kind":"organization","name":"HAEMONETICS CORP"},"owners":[{"id":46227,"kind":"person","name":"Basil Michelle L","position":1,"cik":"0001699629","reported_name":"Basil Michelle L","relationship":{"officer":true,"officer_title":"EVP and General Counsel"}}],"security":"Non-qualified Stock Option (Right to Buy)","published_at":"2023-05-17T20:27:30.000Z","date":"2023-05-15","kind":"grant","planned":false,"acquired":true,"shares":9502,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F5","text":"Option vests in annual increments of 25% beginning on the first anniversary of the date of grant."}],"balance_after":9502,"derivative":{"exercise_price":89.16,"expiration_date":"2030-05-15","underlying":"Common Stock","underlying_shares":9502},"source":{"system":"sec-edgar","filing":"0001127602-23-015931","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/313143/000112760223015931/form4.xml","form_type":"4"}},{"id":1890593,"issuer":{"id":3953,"kind":"organization","name":"HAEMONETICS CORP"},"owners":[{"id":46227,"kind":"person","name":"Basil Michelle L","position":1,"cik":"0001699629","reported_name":"Basil Michelle L","relationship":{"officer":true,"officer_title":"EVP and General Counsel"}}],"security":"Common Stock","published_at":"2023-05-17T20:27:30.000Z","date":"2023-05-16","kind":"tax_withholding","planned":false,"acquired":false,"shares":446,"price":89.21,"value":39787.66,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F4","text":"Represents shares withheld for tax obligations in connection with the vesting of certain RSUs previously reported in Table I."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F3","text":"This number includes unvested RSUs previously reported."}],"balance_after":36010,"source":{"system":"sec-edgar","filing":"0001127602-23-015931","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/313143/000112760223015931/form4.xml","form_type":"4"}},{"id":1890592,"issuer":{"id":3953,"kind":"organization","name":"HAEMONETICS CORP"},"owners":[{"id":46227,"kind":"person","name":"Basil Michelle L","position":1,"cik":"0001699629","reported_name":"Basil Michelle L","relationship":{"officer":true,"officer_title":"EVP and General Counsel"}}],"security":"Common Stock","published_at":"2023-05-17T20:27:30.000Z","date":"2023-05-15","kind":"grant","planned":false,"acquired":true,"shares":4205,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"The securities awarded are in the form of restricted stock units (\"RSUs\") issued pursuant to the Haemonetics Corporation 2019 Long-Term Incentive Compensation Plan. The RSUs vest in three equal annual installments beginning on the first anniversary of the date of grant."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"Each RSU represents a contingent right to receive one (1) share of the Issuer's common stock when vested."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F3","text":"This number includes unvested RSUs previously reported."}],"balance_after":36456,"source":{"system":"sec-edgar","filing":"0001127602-23-015931","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/313143/000112760223015931/form4.xml","form_type":"4"}},{"id":1892676,"issuer":{"id":3953,"kind":"organization","name":"HAEMONETICS CORP"},"owners":[{"id":46227,"kind":"person","name":"Basil Michelle L","position":1,"cik":"0001699629","reported_name":"Basil Michelle L","relationship":{"officer":true,"officer_title":"EVP and General Counsel"}}],"security":"Common Stock","published_at":"2023-05-16T20:17:29.000Z","date":"2023-05-12","kind":"tax_withholding","planned":false,"acquired":false,"shares":204,"price":88.16,"value":17984.64,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents shares withheld for tax obligations in connection with the vesting of certain restricted stock units (\"RSUs\") previously reported in Table I."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"This number includes unvested RSUs previously reported."}],"balance_after":32251,"source":{"system":"sec-edgar","filing":"0001127602-23-015739","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/313143/000112760223015739/form4.xml","form_type":"4"}},{"id":2132055,"issuer":{"id":3953,"kind":"organization","name":"HAEMONETICS CORP"},"owners":[{"id":46227,"kind":"person","name":"Basil Michelle L","position":1,"cik":"0001699629","reported_name":"Basil Michelle L","relationship":{"officer":true,"officer_title":"EVP and General Counsel"}}],"security":"Common Stock","published_at":"2022-10-26T20:35:38.000Z","date":"2022-10-24","kind":"sale","acquired":false,"shares":180,"price":80.39,"value":14470.2,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Represents the number of shares required to be sold by the reporting person to cover tax withholding obligations in connection with the vesting of certain restricted stock units (\"RSUs\") previously reported in Table I following the date of grant. This sale is mandated by the Issuer's election under its 2019 Long Term Incentive Compensation Plan to require the satisfaction of tax withholding obligations to be funded by a \"sell to cover\" transaction and does not represent a discretionary trade by the reporting person."},{"field":"shares","element":"transactionShares","label":"F1","text":"Represents the number of shares required to be sold by the reporting person to cover tax withholding obligations in connection with the vesting of certain restricted stock units (\"RSUs\") previously reported in Table I following the date of grant. This sale is mandated by the Issuer's election under its 2019 Long Term Incentive Compensation Plan to require the satisfaction of tax withholding obligations to be funded by a \"sell to cover\" transaction and does not represent a discretionary trade by the reporting person."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"This number includes unvested restricted stock units (\"RSUs\") previously reported."}],"balance_after":32455,"source":{"system":"sec-edgar","filing":"0001127602-22-024413","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/313143/000112760222024413/form4.xml","form_type":"4"}},{"id":2153748,"issuer":{"id":3953,"kind":"organization","name":"HAEMONETICS CORP"},"owners":[{"id":46227,"kind":"person","name":"Basil Michelle L","position":1,"cik":"0001699629","reported_name":"Basil Michelle L","relationship":{"officer":true,"officer_title":"EVP and General Counsel"}}],"security":"Non-qualified Stock Option (Right to Buy)","published_at":"2022-09-21T20:50:59.000Z","date":"2022-09-19","kind":"exercise","acquired":false,"shares":1011,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Transaction pursuant to an existing 10b5-1 trading plan."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F4","text":"Option vests in annual increments of 25% beginning on the first anniversary of the date of grant."}],"balance_after":12553,"derivative":{"exercise_price":56.57,"expiration_date":"2028-05-18","underlying":"Common Stock","underlying_shares":1011},"source":{"system":"sec-edgar","filing":"0001127602-22-022782","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":7,"url":"https://www.sec.gov/Archives/edgar/data/313143/000112760222022782/form4.xml","form_type":"4"}},{"id":2153747,"issuer":{"id":3953,"kind":"organization","name":"HAEMONETICS CORP"},"owners":[{"id":46227,"kind":"person","name":"Basil Michelle L","position":1,"cik":"0001699629","reported_name":"Basil Michelle L","relationship":{"officer":true,"officer_title":"EVP and General Counsel"}}],"security":"Non-qualified Stock Option (Right to Buy)","published_at":"2022-09-21T20:50:59.000Z","date":"2022-09-19","kind":"exercise","acquired":false,"shares":4213,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Transaction pursuant to an existing 10b5-1 trading plan."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F4","text":"Option vests in annual increments of 25% beginning on the first anniversary of the date of grant."}],"balance_after":0,"derivative":{"exercise_price":41.64,"exercise_date":"2018-06-06","expiration_date":"2024-06-06","underlying":"Common Stock","underlying_shares":4213},"source":{"system":"sec-edgar","filing":"0001127602-22-022782","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":6,"url":"https://www.sec.gov/Archives/edgar/data/313143/000112760222022782/form4.xml","form_type":"4"}},{"id":2153746,"issuer":{"id":3953,"kind":"organization","name":"HAEMONETICS CORP"},"owners":[{"id":46227,"kind":"person","name":"Basil Michelle L","position":1,"cik":"0001699629","reported_name":"Basil Michelle L","relationship":{"officer":true,"officer_title":"EVP and General Counsel"}}],"security":"Non-qualified Stock Option (Right to Buy)","published_at":"2022-09-21T20:50:59.000Z","date":"2022-09-19","kind":"exercise","acquired":false,"shares":3464,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Transaction pursuant to an existing 10b5-1 trading plan."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F4","text":"Option vests in annual increments of 25% beginning on the first anniversary of the date of grant."}],"balance_after":0,"derivative":{"exercise_price":38.43,"exercise_date":"2018-03-06","expiration_date":"2024-03-06","underlying":"Common Stock","underlying_shares":3464},"source":{"system":"sec-edgar","filing":"0001127602-22-022782","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/313143/000112760222022782/form4.xml","form_type":"4"}},{"id":2153745,"issuer":{"id":3953,"kind":"organization","name":"HAEMONETICS CORP"},"owners":[{"id":46227,"kind":"person","name":"Basil Michelle L","position":1,"cik":"0001699629","reported_name":"Basil Michelle L","relationship":{"officer":true,"officer_title":"EVP and General Counsel"}}],"security":"Common Stock","published_at":"2022-09-21T20:50:59.000Z","date":"2022-09-19","kind":"sale","acquired":false,"shares":11448,"price":78.36,"value":897065.28,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Transaction pursuant to an existing 10b5-1 trading plan."},{"field":"price","element":"transactionPricePerShare","label":"F3","text":"The price reported in Column 4 is a weighted average price.  These shares were sold in multiple transactions at prices ranging from $78.00 to $78.75, inclusive.  The reporting person hereby undertakes to provide full information regarding the number of shares and the prices at which the transactions were effected upon request to the staff of the Securities and Exchange Commission, the Issuer, or a security holder of the Issuer."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"This number includes unvested restricted stock units (\"RSUs\") previously reported."}],"balance_after":32635,"source":{"system":"sec-edgar","filing":"0001127602-22-022782","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/313143/000112760222022782/form4.xml","form_type":"4"}},{"id":2153744,"issuer":{"id":3953,"kind":"organization","name":"HAEMONETICS CORP"},"owners":[{"id":46227,"kind":"person","name":"Basil Michelle L","position":1,"cik":"0001699629","reported_name":"Basil Michelle L","relationship":{"officer":true,"officer_title":"EVP and General Counsel"}}],"security":"Common Stock","published_at":"2022-09-21T20:50:59.000Z","date":"2022-09-19","kind":"exercise","acquired":true,"shares":1011,"price":56.57,"value":57192.27,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Transaction pursuant to an existing 10b5-1 trading plan."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"This number includes unvested restricted stock units (\"RSUs\") previously reported."}],"balance_after":44083,"source":{"system":"sec-edgar","filing":"0001127602-22-022782","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/313143/000112760222022782/form4.xml","form_type":"4"}},{"id":2153743,"issuer":{"id":3953,"kind":"organization","name":"HAEMONETICS CORP"},"owners":[{"id":46227,"kind":"person","name":"Basil Michelle L","position":1,"cik":"0001699629","reported_name":"Basil Michelle L","relationship":{"officer":true,"officer_title":"EVP and General Counsel"}}],"security":"Common Stock","published_at":"2022-09-21T20:50:59.000Z","date":"2022-09-19","kind":"exercise","acquired":true,"shares":4213,"price":41.64,"value":175429.32,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Transaction pursuant to an existing 10b5-1 trading plan."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"This number includes unvested restricted stock units (\"RSUs\") previously reported."}],"balance_after":43072,"source":{"system":"sec-edgar","filing":"0001127602-22-022782","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/313143/000112760222022782/form4.xml","form_type":"4"}},{"id":2153742,"issuer":{"id":3953,"kind":"organization","name":"HAEMONETICS CORP"},"owners":[{"id":46227,"kind":"person","name":"Basil Michelle L","position":1,"cik":"0001699629","reported_name":"Basil Michelle L","relationship":{"officer":true,"officer_title":"EVP and General Counsel"}}],"security":"Common Stock","published_at":"2022-09-21T20:50:59.000Z","date":"2022-09-19","kind":"exercise","acquired":true,"shares":3464,"price":38.43,"value":133121.52,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Transaction pursuant to an existing 10b5-1 trading plan."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"This number includes unvested restricted stock units (\"RSUs\") previously reported."}],"balance_after":38859,"source":{"system":"sec-edgar","filing":"0001127602-22-022782","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/313143/000112760222022782/form4.xml","form_type":"4"}},{"id":2156706,"issuer":{"id":3953,"kind":"organization","name":"HAEMONETICS CORP"},"owners":[{"id":46227,"kind":"person","name":"Basil Michelle L","position":1,"cik":"0001699629","reported_name":"Basil Michelle L","relationship":{"officer":true,"officer_title":"EVP and General Counsel"}}],"security":"Non-qualified Stock Option (Right to Buy)","published_at":"2022-09-19T20:39:36.000Z","date":"2022-09-15","kind":"exercise","acquired":false,"shares":3173,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Transaction pursuant to an existing 10b5-1 trading plan."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F5","text":"Option vests in annual increments of 25% beginning on the first anniversary of the date of grant."}],"balance_after":13564,"derivative":{"exercise_price":56.57,"expiration_date":"2028-05-18","underlying":"Common Stock","underlying_shares":3173},"source":{"system":"sec-edgar","filing":"0001127602-22-022683","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":8,"url":"https://www.sec.gov/Archives/edgar/data/313143/000112760222022683/form4.xml","form_type":"4"}},{"id":2156705,"issuer":{"id":3953,"kind":"organization","name":"HAEMONETICS CORP"},"owners":[{"id":46227,"kind":"person","name":"Basil Michelle L","position":1,"cik":"0001699629","reported_name":"Basil Michelle L","relationship":{"officer":true,"officer_title":"EVP and General Counsel"}}],"security":"Non-qualified Stock Option (Right to Buy)","published_at":"2022-09-19T20:39:36.000Z","date":"2022-09-15","kind":"exercise","acquired":false,"shares":14231,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Transaction pursuant to an existing 10b5-1 trading plan."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F5","text":"Option vests in annual increments of 25% beginning on the first anniversary of the date of grant."}],"balance_after":4213,"derivative":{"exercise_price":41.64,"exercise_date":"2018-06-06","expiration_date":"2024-06-06","underlying":"Common Stock","underlying_shares":14231},"source":{"system":"sec-edgar","filing":"0001127602-22-022683","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":7,"url":"https://www.sec.gov/Archives/edgar/data/313143/000112760222022683/form4.xml","form_type":"4"}},{"id":2156704,"issuer":{"id":3953,"kind":"organization","name":"HAEMONETICS CORP"},"owners":[{"id":46227,"kind":"person","name":"Basil Michelle L","position":1,"cik":"0001699629","reported_name":"Basil Michelle L","relationship":{"officer":true,"officer_title":"EVP and General Counsel"}}],"security":"Non-qualified Stock Option (Right to Buy)","published_at":"2022-09-19T20:39:36.000Z","date":"2022-09-15","kind":"exercise","acquired":false,"shares":11154,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Transaction pursuant to an existing 10b5-1 trading plan."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F5","text":"Option vests in annual increments of 25% beginning on the first anniversary of the date of grant."}],"balance_after":3464,"derivative":{"exercise_price":38.43,"exercise_date":"2018-03-06","expiration_date":"2024-03-06","underlying":"Common Stock","underlying_shares":11154},"source":{"system":"sec-edgar","filing":"0001127602-22-022683","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":6,"url":"https://www.sec.gov/Archives/edgar/data/313143/000112760222022683/form4.xml","form_type":"4"}},{"id":2156703,"issuer":{"id":3953,"kind":"organization","name":"HAEMONETICS CORP"},"owners":[{"id":46227,"kind":"person","name":"Basil Michelle L","position":1,"cik":"0001699629","reported_name":"Basil Michelle L","relationship":{"officer":true,"officer_title":"EVP and General Counsel"}}],"security":"Common Stock","published_at":"2022-09-19T20:39:36.000Z","date":"2022-09-15","kind":"sale","acquired":false,"shares":6029,"price":78.5,"value":473276.5,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Transaction pursuant to an existing 10b5-1 trading plan."},{"field":"price","element":"transactionPricePerShare","label":"F4","text":"The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $78.33 to $78.85, inclusive."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"This number includes unvested restricted stock units (\"RSUs\") previously reported."}],"balance_after":35395,"source":{"system":"sec-edgar","filing":"0001127602-22-022683","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/313143/000112760222022683/form4.xml","form_type":"4"}},{"id":2156702,"issuer":{"id":3953,"kind":"organization","name":"HAEMONETICS CORP"},"owners":[{"id":46227,"kind":"person","name":"Basil Michelle L","position":1,"cik":"0001699629","reported_name":"Basil Michelle L","relationship":{"officer":true,"officer_title":"EVP and General Counsel"}}],"security":"Common Stock","published_at":"2022-09-19T20:39:36.000Z","date":"2022-09-15","kind":"sale","acquired":false,"shares":27769,"price":77.76,"value":2159317.44,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Transaction pursuant to an existing 10b5-1 trading plan."},{"field":"price","element":"transactionPricePerShare","label":"F3","text":"The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $77.33 to $78.30, inclusive. The reporting person undertakes to provide to Haemonetics Corporation (\"Haemonetics\"), any security holder of Haemonetics, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in footnotes (3) and (4) to this Form 4."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"This number includes unvested restricted stock units (\"RSUs\") previously reported."}],"balance_after":41424,"source":{"system":"sec-edgar","filing":"0001127602-22-022683","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/313143/000112760222022683/form4.xml","form_type":"4"}},{"id":2156701,"issuer":{"id":3953,"kind":"organization","name":"HAEMONETICS CORP"},"owners":[{"id":46227,"kind":"person","name":"Basil Michelle L","position":1,"cik":"0001699629","reported_name":"Basil Michelle L","relationship":{"officer":true,"officer_title":"EVP and General Counsel"}}],"security":"Common Stock","published_at":"2022-09-19T20:39:36.000Z","date":"2022-09-15","kind":"exercise","acquired":true,"shares":3173,"price":56.57,"value":179496.61,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Transaction pursuant to an existing 10b5-1 trading plan."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"This number includes unvested restricted stock units (\"RSUs\") previously reported."}],"balance_after":69193,"source":{"system":"sec-edgar","filing":"0001127602-22-022683","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/313143/000112760222022683/form4.xml","form_type":"4"}},{"id":2156700,"issuer":{"id":3953,"kind":"organization","name":"HAEMONETICS CORP"},"owners":[{"id":46227,"kind":"person","name":"Basil Michelle L","position":1,"cik":"0001699629","reported_name":"Basil Michelle L","relationship":{"officer":true,"officer_title":"EVP and General Counsel"}}],"security":"Common Stock","published_at":"2022-09-19T20:39:36.000Z","date":"2022-09-15","kind":"exercise","acquired":true,"shares":14231,"price":41.64,"value":592578.84,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Transaction pursuant to an existing 10b5-1 trading plan."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"This number includes unvested restricted stock units (\"RSUs\") previously reported."}],"balance_after":66020,"source":{"system":"sec-edgar","filing":"0001127602-22-022683","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/313143/000112760222022683/form4.xml","form_type":"4"}},{"id":2156699,"issuer":{"id":3953,"kind":"organization","name":"HAEMONETICS CORP"},"owners":[{"id":46227,"kind":"person","name":"Basil Michelle L","position":1,"cik":"0001699629","reported_name":"Basil Michelle L","relationship":{"officer":true,"officer_title":"EVP and General Counsel"}}],"security":"Common Stock","published_at":"2022-09-19T20:39:36.000Z","date":"2022-09-15","kind":"exercise","acquired":true,"shares":11154,"price":38.43,"value":428648.22,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Transaction pursuant to an existing 10b5-1 trading plan."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"This number includes unvested restricted stock units (\"RSUs\") previously reported."}],"balance_after":51789,"source":{"system":"sec-edgar","filing":"0001127602-22-022683","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/313143/000112760222022683/form4.xml","form_type":"4"}},{"id":2232053,"issuer":{"id":3953,"kind":"organization","name":"HAEMONETICS CORP"},"owners":[{"id":46227,"kind":"person","name":"Basil Michelle L","position":1,"cik":"0001699629","reported_name":"Basil Michelle L","relationship":{"officer":true,"officer_title":"EVP and General Counsel"}}],"security":"Common Stock","published_at":"2022-06-15T20:29:24.000Z","date":"2022-06-13","kind":"sale","acquired":false,"shares":277,"price":62.6,"value":17340.2,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Represents the number of shares required to be sold by the reporting person to cover tax withholding obligations in connection with the vesting of certain restricted stock units (\"RSUs\") previously reported in Table I following the date of grant. This sale is mandated by the Issuer's election under its 2005 Long Term Incentive Compensation Plan (as amended) to require the satisfaction of tax withholding obligations to be funded by a \"sell to cover\" transaction and does not represent a discretionary trade by the reporting person."},{"field":"shares","element":"transactionShares","label":"F1","text":"Represents the number of shares required to be sold by the reporting person to cover tax withholding obligations in connection with the vesting of certain restricted stock units (\"RSUs\") previously reported in Table I following the date of grant. This sale is mandated by the Issuer's election under its 2005 Long Term Incentive Compensation Plan (as amended) to require the satisfaction of tax withholding obligations to be funded by a \"sell to cover\" transaction and does not represent a discretionary trade by the reporting person."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"This number includes unvested RSUs previously reported."}],"balance_after":40635,"source":{"system":"sec-edgar","filing":"0001127602-22-017540","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/313143/000112760222017540/form4.xml","form_type":"4"}},{"id":2261069,"issuer":{"id":3953,"kind":"organization","name":"HAEMONETICS CORP"},"owners":[{"id":46227,"kind":"person","name":"Basil Michelle L","position":1,"cik":"0001699629","reported_name":"Basil Michelle L","relationship":{"officer":true,"officer_title":"EVP and General Counsel"}}],"security":"Common Stock","published_at":"2022-05-23T20:08:06.000Z","date":"2022-05-19","kind":"sale","acquired":false,"shares":3258,"price":59.1,"value":192547.8,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Represents the number of shares required to be sold by the reporting person to cover tax withholding obligations in connection with the vesting of certain restricted stock units (\"RSUs\") previously reported in Table I following the date of grant. This sale is mandated by the Issuer's election under its 2019 Long Term Incentive Compensation Plan to require the satisfaction of tax withholding obligations to be funded by a \"sell to cover\" transaction and does not represent a discretionary trade by the reporting person."},{"field":"shares","element":"transactionShares","label":"F1","text":"Represents the number of shares required to be sold by the reporting person to cover tax withholding obligations in connection with the vesting of certain restricted stock units (\"RSUs\") previously reported in Table I following the date of grant. This sale is mandated by the Issuer's election under its 2019 Long Term Incentive Compensation Plan to require the satisfaction of tax withholding obligations to be funded by a \"sell to cover\" transaction and does not represent a discretionary trade by the reporting person."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"This number includes unvested RSUs previously reported."}],"balance_after":40912,"source":{"system":"sec-edgar","filing":"0001127602-22-015363","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/313143/000112760222015363/form4.xml","form_type":"4"}},{"id":2266987,"issuer":{"id":3953,"kind":"organization","name":"HAEMONETICS CORP"},"owners":[{"id":46227,"kind":"person","name":"Basil Michelle L","position":1,"cik":"0001699629","reported_name":"Basil Michelle L","relationship":{"officer":true,"officer_title":"EVP and General Counsel"}}],"security":"Non-qualified Stock Option (Right to Buy)","published_at":"2022-05-18T20:40:47.000Z","date":"2022-05-16","kind":"grant","acquired":true,"shares":14208,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F5","text":"Option vests in annual increments of 25% beginning on the first anniversary of the date of grant."}],"balance_after":14208,"derivative":{"exercise_price":57.6,"expiration_date":"2029-05-16","underlying":"Common Stock","underlying_shares":14208},"source":{"system":"sec-edgar","filing":"0001127602-22-014969","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/313143/000112760222014969/form4.xml","form_type":"4"}},{"id":2266986,"issuer":{"id":3953,"kind":"organization","name":"HAEMONETICS CORP"},"owners":[{"id":46227,"kind":"person","name":"Basil Michelle L","position":1,"cik":"0001699629","reported_name":"Basil Michelle L","relationship":{"officer":true,"officer_title":"EVP and General Counsel"}}],"security":"Common Stock","published_at":"2022-05-18T20:40:47.000Z","date":"2022-05-16","kind":"grant","acquired":true,"shares":6076,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F3","text":"The securities awarded are in the form of RSUs issued pursuant to the Haemonetics Corporation 2019 Long-Term Incentive Compensation Plan. The RSUs vest in annual increments of 25% beginning on the first anniversary of the date of grant."},{"field":"price","element":"transactionPricePerShare","label":"F4","text":"Each RSU represents a contingent right to receive one (1) share of the Issuer's common stock when vested."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"This number includes unvested RSUs previously reported."}],"balance_after":44170,"source":{"system":"sec-edgar","filing":"0001127602-22-014969","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/313143/000112760222014969/form4.xml","form_type":"4"}},{"id":2266985,"issuer":{"id":3953,"kind":"organization","name":"HAEMONETICS CORP"},"owners":[{"id":46227,"kind":"person","name":"Basil Michelle L","position":1,"cik":"0001699629","reported_name":"Basil Michelle L","relationship":{"officer":true,"officer_title":"EVP and General Counsel"}}],"security":"Common Stock","published_at":"2022-05-18T20:40:47.000Z","date":"2022-05-16","kind":"sale","acquired":false,"shares":196,"price":56.1,"value":10995.6,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Represents the number of shares required to be sold by the reporting person to cover tax withholding obligations in connection with the vesting of certain restricted stock units (\"RSUs\") previously reported in Table I following the date of grant. This sale is mandated by the Issuer's election under its 2005 Long Term Incentive Compensation Plan (as amended) to require the satisfaction of tax withholding obligations to be funded by a \"sell to cover\" transaction and does not represent a discretionary trade by the reporting person."},{"field":"shares","element":"transactionShares","label":"F1","text":"Represents the number of shares required to be sold by the reporting person to cover tax withholding obligations in connection with the vesting of certain restricted stock units (\"RSUs\") previously reported in Table I following the date of grant. This sale is mandated by the Issuer's election under its 2005 Long Term Incentive Compensation Plan (as amended) to require the satisfaction of tax withholding obligations to be funded by a \"sell to cover\" transaction and does not represent a discretionary trade by the reporting person."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"This number includes unvested RSUs previously reported."}],"balance_after":38094,"source":{"system":"sec-edgar","filing":"0001127602-22-014969","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/313143/000112760222014969/form4.xml","form_type":"4"}},{"id":2534203,"issuer":{"id":3953,"kind":"organization","name":"HAEMONETICS CORP"},"owners":[{"id":46227,"kind":"person","name":"Basil Michelle L","position":1,"cik":"0001699629","reported_name":"Basil Michelle L","relationship":{"officer":true,"officer_title":"EVP and General Counsel"}}],"security":"Common Stock","published_at":"2021-10-27T20:49:38.000Z","date":"2021-10-25","kind":"sale","acquired":false,"shares":120,"price":71.93,"value":8631.6,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Represents the number of shares required to be sold by the reporting person to cover tax withholding obligations in connection with the vesting of certain restricted stock units (\"RSUs\") previously reported in Table I following the date of grant. This sale is mandated by the Issuer's election under its 2019 Long Term Incentive Compensation Plan to require the satisfaction of tax withholding obligations to be funded by a \"sell to cover\" transaction and does not represent a discretionary trade by the reporting person."},{"field":"shares","element":"transactionShares","label":"F1","text":"Represents the number of shares required to be sold by the reporting person to cover tax withholding obligations in connection with the vesting of certain restricted stock units (\"RSUs\") previously reported in Table I following the date of grant. This sale is mandated by the Issuer's election under its 2019 Long Term Incentive Compensation Plan to require the satisfaction of tax withholding obligations to be funded by a \"sell to cover\" transaction and does not represent a discretionary trade by the reporting person."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"This number includes unvested RSUs previously reported."}],"balance_after":38290,"source":{"system":"sec-edgar","filing":"0001127602-21-027702","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/313143/000112760221027702/form4.xml","form_type":"4"}},{"id":2667267,"issuer":{"id":3953,"kind":"organization","name":"HAEMONETICS CORP"},"owners":[{"id":46227,"kind":"person","name":"Basil Michelle L","position":1,"cik":"0001699629","reported_name":"Basil Michelle L","relationship":{"officer":true,"officer_title":"EVP and General Counsel"}}],"security":"Common Stock","published_at":"2021-06-16T20:35:39.000Z","date":"2021-06-14","kind":"sale","acquired":false,"shares":195,"price":59.87,"value":11674.65,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Represents the number of shares required to be sold by the reporting person to cover tax withholding obligations in connection with the vesting of certain restricted stock units (\"RSUs\") previously reported in Table I following the date of grant. This sale is mandated by the Issuer's election under its 2005 Long Term Incentive Compensation Plan (as amended) to require the satisfaction of tax withholding obligations to be funded by a \"sell to cover\" transaction and does not represent a discretionary trade by the reporting person."},{"field":"shares","element":"transactionShares","label":"F1","text":"Represents the number of shares required to be sold by the reporting person to cover tax withholding obligations in connection with the vesting of certain restricted stock units (\"RSUs\") previously reported in Table I following the date of grant. This sale is mandated by the Issuer's election under its 2005 Long Term Incentive Compensation Plan (as amended) to require the satisfaction of tax withholding obligations to be funded by a \"sell to cover\" transaction and does not represent a discretionary trade by the reporting person."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"This number includes unvested RSUs previously reported."}],"balance_after":38410,"source":{"system":"sec-edgar","filing":"0001127602-21-020055","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/313143/000112760221020055/form4.xml","form_type":"4"}},{"id":2676709,"issuer":{"id":3953,"kind":"organization","name":"HAEMONETICS CORP"},"owners":[{"id":46227,"kind":"person","name":"Basil Michelle L","position":1,"cik":"0001699629","reported_name":"Basil Michelle L","relationship":{"officer":true,"officer_title":"EVP and General Counsel"}}],"security":"Common Stock","published_at":"2021-06-09T20:31:00.000Z","date":"2021-06-07","kind":"sale","acquired":false,"shares":442,"price":55.09,"value":24349.78,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Represents the number of shares required to be sold by the reporting person to cover tax withholding obligations in connection with the vesting of certain restricted stock units (\"RSUs\") previously reported in Table I following the date of grant. This sale is mandated by the Issuer's election under its 2005 Long Term Incentive Compensation Plan (as amended) to require the satisfaction of tax withholding obligations to be funded by a \"sell to cover\" transaction and does not represent a discretionary trade by the reporting person."},{"field":"shares","element":"transactionShares","label":"F1","text":"Represents the number of shares required to be sold by the reporting person to cover tax withholding obligations in connection with the vesting of certain restricted stock units (\"RSUs\") previously reported in Table I following the date of grant. This sale is mandated by the Issuer's election under its 2005 Long Term Incentive Compensation Plan (as amended) to require the satisfaction of tax withholding obligations to be funded by a \"sell to cover\" transaction and does not represent a discretionary trade by the reporting person."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"This number includes unvested RSUs previously reported."}],"balance_after":38605,"source":{"system":"sec-edgar","filing":"0001127602-21-019523","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/313143/000112760221019523/form4.xml","form_type":"4"}},{"id":2704380,"issuer":{"id":3953,"kind":"organization","name":"HAEMONETICS CORP"},"owners":[{"id":46227,"kind":"person","name":"Basil Michelle L","position":1,"cik":"0001699629","reported_name":"Basil Michelle L","relationship":{"officer":true,"officer_title":"EVP and General Counsel"}}],"security":"Non-qualified Stock Option (Right to Buy)","published_at":"2021-05-20T22:02:40.000Z","date":"2021-05-18","kind":"grant","acquired":true,"shares":16737,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F6","text":"Option vests in annual increments of 25% beginning on the first anniversary of the date of grant."}],"balance_after":16737,"derivative":{"exercise_price":56.57,"expiration_date":"2028-05-18","underlying":"Common Stock","underlying_shares":16737},"source":{"system":"sec-edgar","filing":"0001127602-21-017680","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/313143/000112760221017680/form4.xml","form_type":"4"}},{"id":2704379,"issuer":{"id":3953,"kind":"organization","name":"HAEMONETICS CORP"},"owners":[{"id":46227,"kind":"person","name":"Basil Michelle L","position":1,"cik":"0001699629","reported_name":"Basil Michelle L","relationship":{"officer":true,"officer_title":"EVP and General Counsel"}}],"security":"Common Stock","published_at":"2021-05-20T22:02:40.000Z","date":"2021-05-19","kind":"sale","acquired":false,"shares":220,"price":55.19,"value":12141.8,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F5","text":"Represents the number of shares required to be sold by the reporting person to cover tax withholding obligations in connection with the vesting of certain RSUs previously reported in Table I following the date of grant. This sale is mandated by the Issuer's election under its 2019 Long Term Incentive Compensation Plan to require the satisfaction of tax withholding obligations to be funded by a \"sell to cover\" transaction and does not represent a discretionary trade by the reporting person."},{"field":"shares","element":"transactionShares","label":"F5","text":"Represents the number of shares required to be sold by the reporting person to cover tax withholding obligations in connection with the vesting of certain RSUs previously reported in Table I following the date of grant. This sale is mandated by the Issuer's election under its 2019 Long Term Incentive Compensation Plan to require the satisfaction of tax withholding obligations to be funded by a \"sell to cover\" transaction and does not represent a discretionary trade by the reporting person."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F3","text":"This number includes unvested RSUs previously reported."}],"balance_after":39047,"source":{"system":"sec-edgar","filing":"0001127602-21-017680","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/313143/000112760221017680/form4.xml","form_type":"4"}},{"id":2704378,"issuer":{"id":3953,"kind":"organization","name":"HAEMONETICS CORP"},"owners":[{"id":46227,"kind":"person","name":"Basil Michelle L","position":1,"cik":"0001699629","reported_name":"Basil Michelle L","relationship":{"officer":true,"officer_title":"EVP and General Counsel"}}],"security":"Common Stock","published_at":"2021-05-20T22:02:40.000Z","date":"2021-05-18","kind":"grant","acquired":true,"shares":17677,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F4","text":"The securities awarded are in the form of RSUs issued pursuant to the Haemonetics Corporation 2019 Long-Term Incentive Compensation Plan. The RSUs vest in annual increments of 50% beginning on the first anniversary of the date of grant."},{"field":"shares","element":"transactionShares","label":"F4","text":"The securities awarded are in the form of RSUs issued pursuant to the Haemonetics Corporation 2019 Long-Term Incentive Compensation Plan. The RSUs vest in annual increments of 50% beginning on the first anniversary of the date of grant."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"Each RSU represents a contingent right to receive one (1) share of the Issuer's common stock when vested."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F3","text":"This number includes unvested RSUs previously reported."}],"balance_after":39267,"source":{"system":"sec-edgar","filing":"0001127602-21-017680","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/313143/000112760221017680/form4.xml","form_type":"4"}},{"id":2704377,"issuer":{"id":3953,"kind":"organization","name":"HAEMONETICS CORP"},"owners":[{"id":46227,"kind":"person","name":"Basil Michelle L","position":1,"cik":"0001699629","reported_name":"Basil Michelle L","relationship":{"officer":true,"officer_title":"EVP and General Counsel"}}],"security":"Common Stock","published_at":"2021-05-20T22:02:40.000Z","date":"2021-05-18","kind":"grant","acquired":true,"shares":6187,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The securities awarded are in the form of restricted stock units (\"RSUs\") issued pursuant to the Haemonetics Corporation 2019 Long-Term Incentive Compensation Plan. The RSUs vest in annual increments of 25% beginning on the first anniversary of the date of grant."},{"field":"shares","element":"transactionShares","label":"F1","text":"The securities awarded are in the form of restricted stock units (\"RSUs\") issued pursuant to the Haemonetics Corporation 2019 Long-Term Incentive Compensation Plan. The RSUs vest in annual increments of 25% beginning on the first anniversary of the date of grant."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"Each RSU represents a contingent right to receive one (1) share of the Issuer's common stock when vested."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F3","text":"This number includes unvested RSUs previously reported."}],"balance_after":21590,"source":{"system":"sec-edgar","filing":"0001127602-21-017680","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/313143/000112760221017680/form4.xml","form_type":"4"}},{"id":2709504,"issuer":{"id":3953,"kind":"organization","name":"HAEMONETICS CORP"},"owners":[{"id":46227,"kind":"person","name":"Basil Michelle L","position":1,"cik":"0001699629","reported_name":"Basil Michelle L","relationship":{"officer":true,"officer_title":"EVP and General Counsel"}}],"security":"Common Stock","published_at":"2021-05-18T22:25:18.000Z","date":"2021-05-17","kind":"sale","acquired":false,"shares":204,"price":55.97,"value":11417.88,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Represents the number of shares required to be sold by the reporting person to cover tax withholding obligations in connection with the vesting of certain restricted stock units (\"RSUs\") previously reported in Table I following the date of grant. This sale is mandated by the Issuer's election under its 2005 Long Term Incentive Compensation Plan (as amended) to require the satisfaction of tax withholding obligations to be funded by a \"sell to cover\" transaction and does not represent a discretionary trade by the reporting person."},{"field":"shares","element":"transactionShares","label":"F1","text":"Represents the number of shares required to be sold by the reporting person to cover tax withholding obligations in connection with the vesting of certain restricted stock units (\"RSUs\") previously reported in Table I following the date of grant. This sale is mandated by the Issuer's election under its 2005 Long Term Incentive Compensation Plan (as amended) to require the satisfaction of tax withholding obligations to be funded by a \"sell to cover\" transaction and does not represent a discretionary trade by the reporting person."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"This number includes unvested RSUs previously reported."}],"balance_after":15403,"source":{"system":"sec-edgar","filing":"0001127602-21-017263","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/313143/000112760221017263/form4.xml","form_type":"4"}},{"id":2798347,"issuer":{"id":3953,"kind":"organization","name":"HAEMONETICS CORP"},"owners":[{"id":46227,"kind":"person","name":"Basil Michelle L","position":1,"cik":"0001699629","reported_name":"Basil Michelle L","relationship":{"officer":true,"officer_title":"EVP and General Counsel"}}],"security":"Common Stock","published_at":"2021-03-10T21:08:24.000Z","date":"2021-03-08","kind":"sale","acquired":false,"shares":385,"price":120.07,"value":46226.95,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Represents the number of shares required to be sold by the reporting person to cover tax withholding obligations in connection with the vesting of certain restricted stock units (\"RSUs\") previously reported in Table I following the date of grant. This sale is mandated by the Issuer's election under its 2019 Long Term Incentive Compensation Plan to require the satisfaction of tax withholding obligations to be funded by a \"sell to cover\" transaction and does not represent a discretionary trade by the reporting person."},{"field":"shares","element":"transactionShares","label":"F1","text":"Represents the number of shares required to be sold by the reporting person to cover tax withholding obligations in connection with the vesting of certain restricted stock units (\"RSUs\") previously reported in Table I following the date of grant. This sale is mandated by the Issuer's election under its 2019 Long Term Incentive Compensation Plan to require the satisfaction of tax withholding obligations to be funded by a \"sell to cover\" transaction and does not represent a discretionary trade by the reporting person."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"This number includes unvested RSUs previously reported."}],"balance_after":15607,"source":{"system":"sec-edgar","filing":"0001127602-21-010073","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/313143/000112760221010073/form4.xml","form_type":"4"}},{"id":3000287,"issuer":{"id":3953,"kind":"organization","name":"HAEMONETICS CORP"},"owners":[{"id":46227,"kind":"person","name":"Basil Michelle L","position":1,"cik":"0001699629","reported_name":"Basil Michelle L","relationship":{"officer":true,"officer_title":"EVP and General Counsel"}}],"security":"Common Stock","published_at":"2020-10-26T20:55:44.000Z","date":"2020-10-23","kind":"sale","acquired":false,"shares":181,"price":106.58,"value":19290.98,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Represents the number of shares required to be sold by the reporting person to cover tax withholding obligations in connection with the vesting of certain restricted stock units (\"RSUs\") previously reported in Table I following the date of grant. This sale is mandated by the Issuer's election under its 2019 Long Term Incentive Compensation Plan to require the satisfaction of tax withholding obligations to be funded by a \"sell to cover\" transaction and does not represent a discretionary trade by the reporting person."},{"field":"shares","element":"transactionShares","label":"F1","text":"Represents the number of shares required to be sold by the reporting person to cover tax withholding obligations in connection with the vesting of certain restricted stock units (\"RSUs\") previously reported in Table I following the date of grant. This sale is mandated by the Issuer's election under its 2019 Long Term Incentive Compensation Plan to require the satisfaction of tax withholding obligations to be funded by a \"sell to cover\" transaction and does not represent a discretionary trade by the reporting person."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"This number includes unvested RSUs previously reported."}],"balance_after":15992,"source":{"system":"sec-edgar","filing":"0001127602-20-027525","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/313143/000112760220027525/form4.xml","form_type":"4"}},{"id":3109863,"issuer":{"id":3953,"kind":"organization","name":"HAEMONETICS CORP"},"owners":[{"id":46227,"kind":"person","name":"Basil Michelle L","position":1,"cik":"0001699629","reported_name":"Basil Michelle L","relationship":{"officer":true,"officer_title":"EVP and General Counsel"}}],"security":"Common Stock","published_at":"2020-06-16T22:19:02.000Z","date":"2020-06-16","kind":"sale","acquired":false,"shares":1300,"price":92.14,"value":119782.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F5","text":"Transaction pursuant to an existing 10b5-1 trading plan."},{"field":"price","element":"transactionPricePerShare","label":"F8","text":"The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $92.00 to $92.24, inclusive."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"This number includes unvested restricted stock units (\"RSUs\") previously reported."}],"balance_after":16173,"source":{"system":"sec-edgar","filing":"0001127602-20-019791","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":6,"url":"https://www.sec.gov/Archives/edgar/data/313143/000112760220019791/form4.xml","form_type":"4"}},{"id":3109862,"issuer":{"id":3953,"kind":"organization","name":"HAEMONETICS CORP"},"owners":[{"id":46227,"kind":"person","name":"Basil Michelle L","position":1,"cik":"0001699629","reported_name":"Basil Michelle L","relationship":{"officer":true,"officer_title":"EVP and General Counsel"}}],"security":"Common Stock","published_at":"2020-06-16T22:19:02.000Z","date":"2020-06-16","kind":"sale","acquired":false,"shares":6961,"price":91.34,"value":635817.74,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F5","text":"Transaction pursuant to an existing 10b5-1 trading plan."},{"field":"price","element":"transactionPricePerShare","label":"F7","text":"The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $90.95 to $91.93, inclusive."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"This number includes unvested restricted stock units (\"RSUs\") previously reported."}],"balance_after":17473,"source":{"system":"sec-edgar","filing":"0001127602-20-019791","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/313143/000112760220019791/form4.xml","form_type":"4"}},{"id":3109861,"issuer":{"id":3953,"kind":"organization","name":"HAEMONETICS CORP"},"owners":[{"id":46227,"kind":"person","name":"Basil Michelle L","position":1,"cik":"0001699629","reported_name":"Basil Michelle L","relationship":{"officer":true,"officer_title":"EVP and General Counsel"}}],"security":"Common Stock","published_at":"2020-06-16T22:19:02.000Z","date":"2020-06-16","kind":"sale","acquired":false,"shares":5175,"price":90.32,"value":467406.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F5","text":"Transaction pursuant to an existing 10b5-1 trading plan."},{"field":"price","element":"transactionPricePerShare","label":"F6","text":"The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $89.93 to $90.93, inclusive. The reporting person undertakes to provide to Haemonetics Corporation (\"Haemonetics\"), any security holder of Haemonetics, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in footnotes (6) through (8) to this Form 4"},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"This number includes unvested restricted stock units (\"RSUs\") previously reported."}],"balance_after":24434,"source":{"system":"sec-edgar","filing":"0001127602-20-019791","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/313143/000112760220019791/form4.xml","form_type":"4"}},{"id":3109860,"issuer":{"id":3953,"kind":"organization","name":"HAEMONETICS CORP"},"owners":[{"id":46227,"kind":"person","name":"Basil Michelle L","position":1,"cik":"0001699629","reported_name":"Basil Michelle L","relationship":{"officer":true,"officer_title":"EVP and General Counsel"}}],"security":"Common Stock","published_at":"2020-06-16T22:19:02.000Z","date":"2020-06-15","kind":"sale","acquired":false,"shares":10578,"price":87.71,"value":927796.38,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F4","text":"Represents the number of shares required to be sold by the reporting person to cover tax withholding obligations in connection with the vesting of the PSUs reported above on June 12, 2020. This sale is mandated by the Issuer's election under its 2005 Long-Term Incentive Compensation Plan (as amended) to require the satisfaction of tax withholding obligations to be funded by a \"sell to cover\" transaction and does not represent a discretionary trade by the reporting person."},{"field":"shares","element":"transactionShares","label":"F4","text":"Represents the number of shares required to be sold by the reporting person to cover tax withholding obligations in connection with the vesting of the PSUs reported above on June 12, 2020. This sale is mandated by the Issuer's election under its 2005 Long-Term Incentive Compensation Plan (as amended) to require the satisfaction of tax withholding obligations to be funded by a \"sell to cover\" transaction and does not represent a discretionary trade by the reporting person."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"This number includes unvested restricted stock units (\"RSUs\") previously reported."}],"balance_after":29609,"source":{"system":"sec-edgar","filing":"0001127602-20-019791","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/313143/000112760220019791/form4.xml","form_type":"4"}},{"id":3109859,"issuer":{"id":3953,"kind":"organization","name":"HAEMONETICS CORP"},"owners":[{"id":46227,"kind":"person","name":"Basil Michelle L","position":1,"cik":"0001699629","reported_name":"Basil Michelle L","relationship":{"officer":true,"officer_title":"EVP and General Counsel"}}],"security":"Common Stock","published_at":"2020-06-16T22:19:02.000Z","date":"2020-06-12","kind":"sale","acquired":false,"shares":203,"price":89.29,"value":18125.87,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F3","text":"Represents the number of shares required to be sold by the reporting person to cover tax withholding obligations in connection with the vesting of certain RSUs previously reported in Table I following the date of grant.  This sale is mandated by the Issuer's election under its 2005 Long Term Incentive Compensation Plan (as amended) to require the satisfaction of tax withholding obligations to be funded by a \"sell to cover\" transaction and does not represent a discretionary trade by the reporting person."},{"field":"shares","element":"transactionShares","label":"F3","text":"Represents the number of shares required to be sold by the reporting person to cover tax withholding obligations in connection with the vesting of certain RSUs previously reported in Table I following the date of grant.  This sale is mandated by the Issuer's election under its 2005 Long Term Incentive Compensation Plan (as amended) to require the satisfaction of tax withholding obligations to be funded by a \"sell to cover\" transaction and does not represent a discretionary trade by the reporting person."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"This number includes unvested restricted stock units (\"RSUs\") previously reported."}],"balance_after":40187,"source":{"system":"sec-edgar","filing":"0001127602-20-019791","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/313143/000112760220019791/form4.xml","form_type":"4"}},{"id":3109858,"issuer":{"id":3953,"kind":"organization","name":"HAEMONETICS CORP"},"owners":[{"id":46227,"kind":"person","name":"Basil Michelle L","position":1,"cik":"0001699629","reported_name":"Basil Michelle L","relationship":{"officer":true,"officer_title":"EVP and General Counsel"}}],"security":"Common Stock","published_at":"2020-06-16T22:19:02.000Z","date":"2020-06-12","kind":"grant","acquired":true,"shares":24014,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Represents shares earned from a performance share unit (\"PSU\") award granted to the reporting person on June 6, 2017, based on the issuer's total shareholder return relative to that of the companies comprising a blended index of the S&P MidCap 400 and S&P SmallCap 600 for the performance period from June 6, 2017 to June 5, 2020, as certified by the Compensation Committee of the Board of Directors on June 12, 2020."},{"field":"shares","element":"transactionShares","label":"F1","text":"Represents shares earned from a performance share unit (\"PSU\") award granted to the reporting person on June 6, 2017, based on the issuer's total shareholder return relative to that of the companies comprising a blended index of the S&P MidCap 400 and S&P SmallCap 600 for the performance period from June 6, 2017 to June 5, 2020, as certified by the Compensation Committee of the Board of Directors on June 12, 2020."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"This number includes unvested restricted stock units (\"RSUs\") previously reported."}],"balance_after":40390,"source":{"system":"sec-edgar","filing":"0001127602-20-019791","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/313143/000112760220019791/form4.xml","form_type":"4"}},{"id":3115573,"issuer":{"id":3953,"kind":"organization","name":"HAEMONETICS CORP"},"owners":[{"id":46227,"kind":"person","name":"Basil Michelle L","position":1,"cik":"0001699629","reported_name":"Basil Michelle L","relationship":{"officer":true,"officer_title":"EVP and General Counsel"}}],"security":"Common Stock","published_at":"2020-06-10T21:57:03.000Z","date":"2020-06-08","kind":"sale","acquired":false,"shares":687,"price":97.03,"value":66659.61,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Represents the number of shares required to be sold by the reporting person to cover tax withholding obligations in connection with the vesting of certain restricted stock units (\"RSUs\") previously reported in Table I following the date of grant.  This sale is mandated by the Issuer's election under its 2005 Long Term Incentive Compensation Plan (as amended) to require the satisfaction of tax withholding obligations to be funded by a \"sell to cover\" transaction and does not represent a discretionary trade by the reporting person."},{"field":"shares","element":"transactionShares","label":"F1","text":"Represents the number of shares required to be sold by the reporting person to cover tax withholding obligations in connection with the vesting of certain restricted stock units (\"RSUs\") previously reported in Table I following the date of grant.  This sale is mandated by the Issuer's election under its 2005 Long Term Incentive Compensation Plan (as amended) to require the satisfaction of tax withholding obligations to be funded by a \"sell to cover\" transaction and does not represent a discretionary trade by the reporting person."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"This number includes unvested RSUs previously reported."}],"balance_after":16376,"source":{"system":"sec-edgar","filing":"0001127602-20-019379","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/313143/000112760220019379/form4.xml","form_type":"4"}},{"id":3144565,"issuer":{"id":3953,"kind":"organization","name":"HAEMONETICS CORP"},"owners":[{"id":46227,"kind":"person","name":"Basil Michelle L","position":1,"cik":"0001699629","reported_name":"Basil Michelle L","relationship":{"officer":true,"officer_title":"EVP and General Counsel"}}],"security":"Non-qualified Stock Option (Right to Buy)","published_at":"2020-05-19T21:20:20.000Z","date":"2020-05-18","kind":"grant","acquired":true,"shares":9821,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F5","text":"Option vests in annual increments of 25% beginning on the first anniversary of the date of grant."}],"balance_after":9821,"derivative":{"exercise_price":103.37,"expiration_date":"2027-05-18","underlying":"Common Stock","underlying_shares":9821},"source":{"system":"sec-edgar","filing":"0001127602-20-017249","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/313143/000112760220017249/form4.xml","form_type":"4"}},{"id":3144564,"issuer":{"id":3953,"kind":"organization","name":"HAEMONETICS CORP"},"owners":[{"id":46227,"kind":"person","name":"Basil Michelle L","position":1,"cik":"0001699629","reported_name":"Basil Michelle L","relationship":{"officer":true,"officer_title":"EVP and General Counsel"}}],"security":"Common Stock","published_at":"2020-05-19T21:20:20.000Z","date":"2020-05-18","kind":"grant","acquired":true,"shares":2902,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F3","text":"The securities awarded are in the form of RSUs issued pursuant to the Haemonetics Corporation 2019 Long-Term Incentive Compensation Plan. The RSUs vest in annual increments of 25% beginning on the first anniversary of the date of grant."},{"field":"shares","element":"transactionShares","label":"F3","text":"The securities awarded are in the form of RSUs issued pursuant to the Haemonetics Corporation 2019 Long-Term Incentive Compensation Plan. The RSUs vest in annual increments of 25% beginning on the first anniversary of the date of grant."},{"field":"price","element":"transactionPricePerShare","label":"F4","text":"Each RSU represents a contingent right to receive one (1) share of the Issuer's common stock when vested."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"This number includes unvested RSUs previously reported."}],"balance_after":17063,"source":{"system":"sec-edgar","filing":"0001127602-20-017249","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/313143/000112760220017249/form4.xml","form_type":"4"}},{"id":3144563,"issuer":{"id":3953,"kind":"organization","name":"HAEMONETICS CORP"},"owners":[{"id":46227,"kind":"person","name":"Basil Michelle L","position":1,"cik":"0001699629","reported_name":"Basil Michelle L","relationship":{"officer":true,"officer_title":"EVP and General Counsel"}}],"security":"Common Stock","published_at":"2020-05-19T21:20:20.000Z","date":"2020-05-15","kind":"sale","acquired":false,"shares":203,"price":100.44,"value":20389.32,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Represents the number of shares required to be sold by the reporting person to cover tax withholding obligations in connection with the vesting of certain restricted stock units (\"RSUs\") previously reported in Table I following the date of grant.  This sale is mandated by the Issuer's election under its 2005 Long Term Incentive Compensation Plan to require the satisfaction of tax withholding obligations to be funded by a \"sell to cover\" transaction and does not represent a discretionary trade by the reporting person."},{"field":"shares","element":"transactionShares","label":"F1","text":"Represents the number of shares required to be sold by the reporting person to cover tax withholding obligations in connection with the vesting of certain restricted stock units (\"RSUs\") previously reported in Table I following the date of grant.  This sale is mandated by the Issuer's election under its 2005 Long Term Incentive Compensation Plan to require the satisfaction of tax withholding obligations to be funded by a \"sell to cover\" transaction and does not represent a discretionary trade by the reporting person."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"This number includes unvested RSUs previously reported."}],"balance_after":14161,"source":{"system":"sec-edgar","filing":"0001127602-20-017249","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/313143/000112760220017249/form4.xml","form_type":"4"}},{"id":3219296,"issuer":{"id":3953,"kind":"organization","name":"HAEMONETICS CORP"},"owners":[{"id":46227,"kind":"person","name":"Basil Michelle L","position":1,"cik":"0001699629","reported_name":"Basil Michelle L","relationship":{"officer":true,"officer_title":"EVP and General Counsel"}}],"security":"Common Stock","published_at":"2020-03-10T22:16:47.000Z","date":"2020-03-09","kind":"sale","acquired":false,"shares":395,"price":98,"value":38710.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Represents the number of shares required to be sold by the reporting person to cover tax withholding obligations in connection with the vesting of certain restricted stock units previously reported in Table I following the date of grant. This sale is mandated by the Issuer's election under its 2005 Long Term Incentive Compensation Plan to require the satisfaction of tax withholding obligations to be funded by a \"sell to cover\" transaction and does not represent a discretionary trade by the reporting person."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"This number includes unvested restricted stock units previously reported."}],"balance_after":14364,"source":{"system":"sec-edgar","filing":"0001127602-20-010130","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/313143/000112760220010130/form4.xml","form_type":"4"}},{"id":3389560,"issuer":{"id":3953,"kind":"organization","name":"HAEMONETICS CORP"},"owners":[{"id":46227,"kind":"person","name":"Basil Michelle L","position":1,"cik":"0001699629","reported_name":"Basil Michelle L","relationship":{"officer":true,"officer_title":"EVP and General Counsel"}}],"security":"Common Stock","published_at":"2019-10-23T20:38:42.000Z","date":"2019-10-22","kind":"grant","acquired":true,"shares":1621,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"The securities awarded are in the form of restricted stock units (\"RSUs\") issued pursuant to the Haemonetics Corporation 2019 Long-Term Incentive Compensation Plan. The RSUs vest in annual increments of 25% beginning on the first anniversary of the date of grant."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"Each RSU represents a contingent right to receive one (1) share of the Issuer's common stock when vested."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F3","text":"This number includes unvested RSUs previously reported."}],"balance_after":14759,"source":{"system":"sec-edgar","filing":"0001127602-19-030959","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/313143/000112760219030959/form4.xml","form_type":"4"}},{"id":3394950,"issuer":{"id":3953,"kind":"organization","name":"HAEMONETICS CORP"},"owners":[{"id":46227,"kind":"person","name":"Basil Michelle L","position":1,"cik":"0001699629","reported_name":"Basil Michelle L","relationship":{"officer":true,"officer_title":"EVP and General Counsel"}}],"security":"Common Stock","published_at":"2019-10-10T20:56:47.000Z","date":"2019-10-09","kind":"sale","acquired":false,"shares":5809,"price":124.54,"value":723452.86,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F3","text":"Transaction pursuant to an existing 10b5-1 trading plan."},{"field":"price","element":"transactionPricePerShare","label":"F6","text":"The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $124.09 to $124.96, inclusive."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"This number includes unvested restricted stock units previously reported."}],"balance_after":13138,"source":{"system":"sec-edgar","filing":"0001127602-19-030385","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/313143/000112760219030385/form4.xml","form_type":"4"}},{"id":3394949,"issuer":{"id":3953,"kind":"organization","name":"HAEMONETICS CORP"},"owners":[{"id":46227,"kind":"person","name":"Basil Michelle L","position":1,"cik":"0001699629","reported_name":"Basil Michelle L","relationship":{"officer":true,"officer_title":"EVP and General Counsel"}}],"security":"Common Stock","published_at":"2019-10-10T20:56:47.000Z","date":"2019-10-09","kind":"sale","acquired":false,"shares":3724,"price":123.5,"value":459914.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F3","text":"Transaction pursuant to an existing 10b5-1 trading plan."},{"field":"price","element":"transactionPricePerShare","label":"F5","text":"The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $123.09 to $124.02, inclusive."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"This number includes unvested restricted stock units previously reported."}],"balance_after":18947,"source":{"system":"sec-edgar","filing":"0001127602-19-030385","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/313143/000112760219030385/form4.xml","form_type":"4"}},{"id":3394948,"issuer":{"id":3953,"kind":"organization","name":"HAEMONETICS CORP"},"owners":[{"id":46227,"kind":"person","name":"Basil Michelle L","position":1,"cik":"0001699629","reported_name":"Basil Michelle L","relationship":{"officer":true,"officer_title":"EVP and General Counsel"}}],"security":"Common Stock","published_at":"2019-10-10T20:56:47.000Z","date":"2019-10-09","kind":"sale","acquired":false,"shares":1100,"price":122.5,"value":134750.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F3","text":"Transaction pursuant to an existing 10b5-1 trading plan."},{"field":"price","element":"transactionPricePerShare","label":"F4","text":"The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $122.02 to $123.00, inclusive. The reporting person undertakes to provide to Haemonetics Corporation (\"Haemonetics\"), any security holder of Haemonetics, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in footnotes (4) through (6) to this Form 4."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"This number includes unvested restricted stock units previously reported."}],"balance_after":22671,"source":{"system":"sec-edgar","filing":"0001127602-19-030385","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/313143/000112760219030385/form4.xml","form_type":"4"}},{"id":3394947,"issuer":{"id":3953,"kind":"organization","name":"HAEMONETICS CORP"},"owners":[{"id":46227,"kind":"person","name":"Basil Michelle L","position":1,"cik":"0001699629","reported_name":"Basil Michelle L","relationship":{"officer":true,"officer_title":"EVP and General Counsel"}}],"security":"Common Stock","published_at":"2019-10-10T20:56:47.000Z","date":"2019-10-08","kind":"sale","acquired":false,"shares":8883,"price":122.34,"value":1086746.22,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Represents the number of shares required to be sold by the reporting person to cover tax withholding obligations in connection with the vesting of certain performance share units previously reported in Table I on October 8, 2019. This sale is mandated by the Issuer's election under its 2005 Long Term Incentive Compensation Plan to require the satisfaction of tax withholding obligations to be funded by a \"sell to cover\" transaction and does not represent a discretionary trade by the reporting person."},{"field":"shares","element":"transactionShares","label":"F1","text":"Represents the number of shares required to be sold by the reporting person to cover tax withholding obligations in connection with the vesting of certain performance share units previously reported in Table I on October 8, 2019. This sale is mandated by the Issuer's election under its 2005 Long Term Incentive Compensation Plan to require the satisfaction of tax withholding obligations to be funded by a \"sell to cover\" transaction and does not represent a discretionary trade by the reporting person."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"This number includes unvested restricted stock units previously reported."}],"balance_after":23771,"source":{"system":"sec-edgar","filing":"0001127602-19-030385","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/313143/000112760219030385/form4.xml","form_type":"4"}},{"id":3396335,"issuer":{"id":3953,"kind":"organization","name":"HAEMONETICS CORP"},"owners":[{"id":46227,"kind":"person","name":"Basil Michelle L","position":1,"cik":"0001699629","reported_name":"Basil Michelle L","relationship":{"officer":true,"officer_title":"EVP and General Counsel"}}],"security":"Common Stock","published_at":"2019-10-08T20:35:59.000Z","date":"2019-10-04","kind":"grant","acquired":true,"shares":19516,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Represents shares earned from a performance share unit award granted to the reporting person on March 6, 2017, based on the issuer's total shareholder return relative to that of the companies comprising a blended index of the S&P MidCap 400 and S&P SmallCap 600 for the performance period from October 1, 2016 to September 30, 2019, as certified by the Compensation Committee of the Board of Directors on October 4, 2019."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"This number includes unvested restricted stock units previously reported."}],"balance_after":32654,"source":{"system":"sec-edgar","filing":"0001127602-19-030269","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/313143/000112760219030269/form4.xml","form_type":"4"}},{"id":3492071,"issuer":{"id":3953,"kind":"organization","name":"HAEMONETICS CORP"},"owners":[{"id":46227,"kind":"person","name":"Basil Michelle L","position":1,"cik":"0001699629","reported_name":"Basil Michelle L","relationship":{"officer":true,"officer_title":"EVP and General Counsel"}}],"security":"Common Stock","published_at":"2019-06-13T20:29:09.000Z","date":"2019-06-12","kind":"sale","acquired":false,"shares":231,"price":109.37,"value":25264.47,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents the number of shares required to be sold by the reporting person to cover tax withholding obligations in connection with the vesting of certain restricted stock units previously reported in Table I following the date of grant.  This sale is mandated by the Issuer's election under its 2005 Long Term Incentive Compensation Plan to require the satisfaction of tax withholding obligations to be funded by a \"sell to cover\" transaction and does not represent a discretionary trade by the reporting person."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"This number includes unvested restricted stock units previously reported."}],"balance_after":13138,"source":{"system":"sec-edgar","filing":"0001127602-19-021561","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/313143/000112760219021561/form4.xml","form_type":"4"}},{"id":3496526,"issuer":{"id":3953,"kind":"organization","name":"HAEMONETICS CORP"},"owners":[{"id":46227,"kind":"person","name":"Basil Michelle L","position":1,"cik":"0001699629","reported_name":"Basil Michelle L","relationship":{"officer":true,"officer_title":"EVP and General Counsel"}}],"security":"Non-qualified Stock Option (Right to Buy)","published_at":"2019-06-10T20:22:48.000Z","date":"2019-06-07","kind":"exercise","acquired":false,"shares":4872,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Transaction pursuant to an existing 10b5-1 trading plan."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F4","text":"Grant to reporting person of right to buy shares of common stock exercisable in annual increments of 25 percent beginning on the first anniversary of the date of grant."}],"balance_after":14618,"derivative":{"exercise_price":38.43,"exercise_date":"2018-03-06","expiration_date":"2024-03-06","underlying":"Common Stock","underlying_shares":4872},"source":{"system":"sec-edgar","filing":"0001127602-19-021236","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":7,"url":"https://www.sec.gov/Archives/edgar/data/313143/000112760219021236/form4.xml","form_type":"4"}},{"id":3496525,"issuer":{"id":3953,"kind":"organization","name":"HAEMONETICS CORP"},"owners":[{"id":46227,"kind":"person","name":"Basil Michelle L","position":1,"cik":"0001699629","reported_name":"Basil Michelle L","relationship":{"officer":true,"officer_title":"EVP and General Counsel"}}],"security":"Non-qualified Stock Option (Right to Buy)","published_at":"2019-06-10T20:22:48.000Z","date":"2019-06-06","kind":"exercise","acquired":false,"shares":6148,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Transaction pursuant to an existing 10b5-1 trading plan."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F4","text":"Grant to reporting person of right to buy shares of common stock exercisable in annual increments of 25 percent beginning on the first anniversary of the date of grant."}],"balance_after":18444,"derivative":{"exercise_price":41.64,"exercise_date":"2018-06-06","expiration_date":"2024-06-06","underlying":"Common Stock","underlying_shares":6148},"source":{"system":"sec-edgar","filing":"0001127602-19-021236","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":6,"url":"https://www.sec.gov/Archives/edgar/data/313143/000112760219021236/form4.xml","form_type":"4"}},{"id":3496524,"issuer":{"id":3953,"kind":"organization","name":"HAEMONETICS CORP"},"owners":[{"id":46227,"kind":"person","name":"Basil Michelle L","position":1,"cik":"0001699629","reported_name":"Basil Michelle L","relationship":{"officer":true,"officer_title":"EVP and General Counsel"}}],"security":"Common Stock","published_at":"2019-06-10T20:22:48.000Z","date":"2019-06-07","kind":"sale","acquired":false,"shares":442,"price":103.38,"value":45693.96,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F3","text":"Represents the number of shares required to be sold by the reporting person to cover tax withholding obligations in connection with the vesting of certain restricted stock units previously reported in Table I following the date of grant.  This sale is mandated by the Issuer's election under its 2005 Long Term Incentive Compensation Plan to require the satisfaction of tax withholding obligations to be funded by a \"sell to cover\" transaction and does not represent a discretionary trade by the reporting person."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"This number includes unvested RSUs previously reported."}],"balance_after":13369,"source":{"system":"sec-edgar","filing":"0001127602-19-021236","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/313143/000112760219021236/form4.xml","form_type":"4"}},{"id":3496523,"issuer":{"id":3953,"kind":"organization","name":"HAEMONETICS CORP"},"owners":[{"id":46227,"kind":"person","name":"Basil Michelle L","position":1,"cik":"0001699629","reported_name":"Basil Michelle L","relationship":{"officer":true,"officer_title":"EVP and General Counsel"}}],"security":"Common Stock","published_at":"2019-06-10T20:22:48.000Z","date":"2019-06-07","kind":"sale","acquired":false,"shares":6745,"price":103.5,"value":698107.5,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Transaction pursuant to an existing 10b5-1 trading plan."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"This number includes unvested RSUs previously reported."}],"balance_after":13811,"source":{"system":"sec-edgar","filing":"0001127602-19-021236","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/313143/000112760219021236/form4.xml","form_type":"4"}},{"id":3496522,"issuer":{"id":3953,"kind":"organization","name":"HAEMONETICS CORP"},"owners":[{"id":46227,"kind":"person","name":"Basil Michelle L","position":1,"cik":"0001699629","reported_name":"Basil Michelle L","relationship":{"officer":true,"officer_title":"EVP and General Counsel"}}],"security":"Common Stock","published_at":"2019-06-10T20:22:48.000Z","date":"2019-06-07","kind":"exercise","acquired":true,"shares":4872,"price":38.43,"value":187230.96,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Transaction pursuant to an existing 10b5-1 trading plan."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"This number includes unvested RSUs previously reported."}],"balance_after":20556,"source":{"system":"sec-edgar","filing":"0001127602-19-021236","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/313143/000112760219021236/form4.xml","form_type":"4"}},{"id":3496521,"issuer":{"id":3953,"kind":"organization","name":"HAEMONETICS CORP"},"owners":[{"id":46227,"kind":"person","name":"Basil Michelle L","position":1,"cik":"0001699629","reported_name":"Basil Michelle L","relationship":{"officer":true,"officer_title":"EVP and General Counsel"}}],"security":"Common Stock","published_at":"2019-06-10T20:22:48.000Z","date":"2019-06-06","kind":"sale","acquired":false,"shares":6148,"price":103.25,"value":634781.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Transaction pursuant to an existing 10b5-1 trading plan."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"This number includes unvested RSUs previously reported."}],"balance_after":15684,"source":{"system":"sec-edgar","filing":"0001127602-19-021236","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/313143/000112760219021236/form4.xml","form_type":"4"}},{"id":3496520,"issuer":{"id":3953,"kind":"organization","name":"HAEMONETICS CORP"},"owners":[{"id":46227,"kind":"person","name":"Basil Michelle L","position":1,"cik":"0001699629","reported_name":"Basil Michelle L","relationship":{"officer":true,"officer_title":"EVP and General Counsel"}}],"security":"Common Stock","published_at":"2019-06-10T20:22:48.000Z","date":"2019-06-06","kind":"exercise","acquired":true,"shares":6148,"price":41.64,"value":256002.72,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Transaction pursuant to an existing 10b5-1 trading plan."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"This number includes unvested RSUs previously reported."}],"balance_after":21832,"source":{"system":"sec-edgar","filing":"0001127602-19-021236","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/313143/000112760219021236/form4.xml","form_type":"4"}},{"id":3525135,"issuer":{"id":3953,"kind":"organization","name":"HAEMONETICS CORP"},"owners":[{"id":46227,"kind":"person","name":"Basil Michelle L","position":1,"cik":"0001699629","reported_name":"Basil Michelle L","relationship":{"officer":true,"officer_title":"EVP and General Counsel"}}],"security":"Non-qualified Stock Option (Right to Buy)","published_at":"2019-05-16T20:19:54.000Z","date":"2019-05-14","kind":"grant","acquired":true,"shares":9794,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F4","text":"Option vests in annual increments of 25% beginning on the first anniversary of the date of grant."}],"balance_after":9794,"derivative":{"exercise_price":98.025,"expiration_date":"2026-05-14","underlying":"Common Stock","underlying_shares":9794},"source":{"system":"sec-edgar","filing":"0001127602-19-018733","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/313143/000112760219018733/form4.xml","form_type":"4"}},{"id":3525134,"issuer":{"id":3953,"kind":"organization","name":"HAEMONETICS CORP"},"owners":[{"id":46227,"kind":"person","name":"Basil Michelle L","position":1,"cik":"0001699629","reported_name":"Basil Michelle L","relationship":{"officer":true,"officer_title":"EVP and General Counsel"}}],"security":"Common Stock","published_at":"2019-05-16T20:19:54.000Z","date":"2019-05-14","kind":"grant","acquired":true,"shares":2805,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"The securities awarded are in the form of restricted stock units (\"RSUs\") issued pursuant to the Haemonetics Corporation 2005 Long-Term Incentive Compensation Plan (as amended). The RSUs vest in annual increments of 25% beginning on the first anniversary of the date of grant."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"Each RSU represents a contingent right to receive one (1) share of the Issuer's common stock when vested."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F3","text":"This number includes unvested RSUs previously reported."}],"balance_after":15684,"source":{"system":"sec-edgar","filing":"0001127602-19-018733","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/313143/000112760219018733/form4.xml","form_type":"4"}},{"id":3603346,"issuer":{"id":3953,"kind":"organization","name":"HAEMONETICS CORP"},"owners":[{"id":46227,"kind":"person","name":"Basil Michelle L","position":1,"cik":"0001699629","reported_name":"Basil Michelle L","relationship":{"officer":true,"officer_title":"EVP and General Counsel"}}],"security":"Common Stock","published_at":"2019-03-11T21:10:50.000Z","date":"2019-03-07","kind":"sale","acquired":false,"shares":391,"price":83.57,"value":32675.87,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents the number of shares required to be sold by the reporting person to cover tax withholding obligations in connection with the vesting of certain restricted stock units previously reported in Table I following the date of grant. This sale is mandated by the Issuer's election under its 2005 Long Term Incentive Compensation Plan to require the satisfaction of tax withholding obligations to be funded by a \"sell to cover\" transaction and does not represent a discretionary trade by the reporting person."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"This number includes unvested restricted stock units previously reported."}],"balance_after":12879,"source":{"system":"sec-edgar","filing":"0001127602-19-010837","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/313143/000112760219010837/form4.xml","form_type":"4"}},{"id":3896162,"issuer":{"id":3953,"kind":"organization","name":"HAEMONETICS CORP"},"owners":[{"id":46227,"kind":"person","name":"Basil Michelle L","position":1,"cik":"0001699629","reported_name":"Basil Michelle L","relationship":{"officer":true,"officer_title":"EVP and General Counsel"}}],"security":"Non-qualified Stock Option (Right to Buy)","published_at":"2018-06-13T23:22:43.000Z","date":"2018-06-11","kind":"grant","acquired":true,"shares":9516,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F4","text":"Option vests in annual increments of 25% beginning on the first anniversary of the date of grant."}],"balance_after":9516,"derivative":{"exercise_price":93.52,"expiration_date":"2025-06-11","underlying":"Common Stock","underlying_shares":9516},"source":{"system":"sec-edgar","filing":"0001127602-18-020837","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/313143/000112760218020837/form4.xml","form_type":"4"}},{"id":3896161,"issuer":{"id":3953,"kind":"organization","name":"HAEMONETICS CORP"},"owners":[{"id":46227,"kind":"person","name":"Basil Michelle L","position":1,"cik":"0001699629","reported_name":"Basil Michelle L","relationship":{"officer":true,"officer_title":"EVP and General Counsel"}}],"security":"Common Stock","published_at":"2018-06-13T23:22:43.000Z","date":"2018-06-11","kind":"grant","acquired":true,"shares":2673,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"The securities awarded are in the form of restricted stock units (\"RSUs\") issued pursuant to the Haemonetics Corporation 2005 Long-Term Incentive Compensation Plan (as amended). The RSUs vest in annual increments of 25% beginning on the first anniversary of the date of grant."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"Each RSU represents a contingent right to receive one (1) share of the Issuer's common stock when vested."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F3","text":"This number includes unvested restricted stock units previously reported."}],"balance_after":13270,"source":{"system":"sec-edgar","filing":"0001127602-18-020837","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/313143/000112760218020837/form4.xml","form_type":"4"}},{"id":3901003,"issuer":{"id":3953,"kind":"organization","name":"HAEMONETICS CORP"},"owners":[{"id":46227,"kind":"person","name":"Basil Michelle L","position":1,"cik":"0001699629","reported_name":"Basil Michelle L","relationship":{"officer":true,"officer_title":"EVP and General Counsel"}}],"security":"Common Stock","published_at":"2018-06-08T20:31:43.000Z","date":"2018-06-07","kind":"sale","acquired":false,"shares":457,"price":92.73,"value":42377.61,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents the number of shares required to be sold by the reporting person to cover tax withholding obligations in connection with the vesting of certain restricted stock units previously reported in Table I following the date of grant.  This sale is mandated by the Issuer's election under its 2005 Long Term Incentive Compensation Plan to require the satisfaction of tax withholding obligations to be funded by a \"sell to cover\" transaction and does not represent a discretionary trade by the reporting person."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"This number includes unvested restricted stock units previously reported as well as 268 shares purchased by the reporting person under the Issuer's 2007 Employee Stock Purchase Plan (as amended) on April 30, 2018."}],"balance_after":10597,"source":{"system":"sec-edgar","filing":"0001127602-18-020484","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/313143/000112760218020484/form4.xml","form_type":"4"}},{"id":4007005,"issuer":{"id":3953,"kind":"organization","name":"HAEMONETICS CORP"},"owners":[{"id":46227,"kind":"person","name":"Basil Michelle L","position":1,"cik":"0001699629","reported_name":"Basil Michelle L","relationship":{"officer":true,"officer_title":"EVP and General Counsel"}}],"security":"Common Stock","published_at":"2018-03-08T22:01:58.000Z","date":"2018-03-06","kind":"sale","acquired":false,"shares":389,"price":72.23,"value":28097.47,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents the number of shares required to be sold by the reporting person to cover tax withholding obligations in connection with the vesting of certain restricted stock units previously reported in Table I following the date of grant.  This sale is mandated by the Issuer's election under its 2005 Long Term Incentive Compensation Plan to require the satisfaction of tax withholding obligations to be funded by a \"sell to cover\" transaction and does not represent a discretionary trade by the reporting person."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"This number includes 293 shares purchased by the reporting person under the Issuer's 2007 Employee Stock Purchase Plan (as amended) on October 31, 2017."}],"balance_after":10786,"source":{"system":"sec-edgar","filing":"0001127602-18-010742","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/313143/000112760218010742/form4.xml","form_type":"4"}},{"id":4289151,"issuer":{"id":3953,"kind":"organization","name":"HAEMONETICS CORP"},"owners":[{"id":46227,"kind":"person","name":"Basil Michelle L","position":1,"cik":"0001699629","reported_name":"Basil Michelle L","relationship":{"officer":true,"officer_title":"EVP and General Counsel"}}],"security":"Non-qualified Stock Option (Right to Buy)","published_at":"2017-06-08T21:57:08.000Z","date":"2017-06-06","kind":"grant","acquired":true,"shares":24592,"price":41.64,"value":1024010.88,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"Grant to reporting person of right to buy shares of common stock exercisable in annual increments of 25 percent beginning on the first anniversary of the date of grant."}],"balance_after":24592,"derivative":{"exercise_price":41.64,"exercise_date":"2018-06-06","expiration_date":"2024-06-06","underlying":"Common Stock","underlying_shares":24592},"source":{"system":"sec-edgar","filing":"0001127602-17-020969","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/313143/000112760217020969/form4.xml","form_type":"4"}},{"id":4289150,"issuer":{"id":3953,"kind":"organization","name":"HAEMONETICS CORP"},"owners":[{"id":46227,"kind":"person","name":"Basil Michelle L","position":1,"cik":"0001699629","reported_name":"Basil Michelle L","relationship":{"officer":true,"officer_title":"EVP and General Counsel"}}],"security":"Common Stock","published_at":"2017-06-08T21:57:08.000Z","date":"2017-06-06","kind":"grant","acquired":true,"shares":6003,"price":41.64,"value":249964.92,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Restricted Stock Unit Grant which vest 25% per year over 4 years following the grant date. Grant was made under 2005 Long Term Incentive Compensation Plan."}],"balance_after":10882,"source":{"system":"sec-edgar","filing":"0001127602-17-020969","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/313143/000112760217020969/form4.xml","form_type":"4"}},{"id":4396168,"issuer":{"id":3953,"kind":"organization","name":"HAEMONETICS CORP"},"owners":[{"id":46227,"kind":"person","name":"Basil Michelle L","position":1,"cik":"0001699629","reported_name":"Basil Michelle L","relationship":{"officer":true,"officer_title":"EVP and General Counsel"}}],"security":"Performance Shares","published_at":"2017-03-08T22:21:45.000Z","date":"2017-03-06","kind":"grant","acquired":true,"shares":9758,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"Performance Share Units represent a right to receive one share of Haemonetics Corporation common stock for each Performance Share Unit based on the performance of Haemonetics stock price relative to the Total Shareholder Return of the companies comprising a blended index of the S&P MidCap 400 and S&P SmallCap 600. The number of Performance Share Units (and therefore the number of shares payable) will depend on the Company's stock price performance between October 1, 2016 and September 30, 2019. The Performance Share Units disclosed in column 5 represent a target amount. The number of shares ultimately issued could range from none to twice the target amount in column 5. The Performance Share Units were granted under the 2005 Haemonetics Corporation Long-Term Incentive Compensation Plan and are exempt under Rule 16b-3(d)."}],"balance_after":19516,"derivative":{"exercise_price":0,"exercise_date":"2019-09-30","expiration_date":"2019-12-31","underlying":"Common Stock","underlying_shares":9758},"source":{"system":"sec-edgar","filing":"0001127602-17-010886","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/313143/000112760217010886/form4.xml","form_type":"4"}},{"id":4396167,"issuer":{"id":3953,"kind":"organization","name":"HAEMONETICS CORP"},"owners":[{"id":46227,"kind":"person","name":"Basil Michelle L","position":1,"cik":"0001699629","reported_name":"Basil Michelle L","relationship":{"officer":true,"officer_title":"EVP and General Counsel"}}],"security":"Non-qualified Stock Option (Right to Buy)","published_at":"2017-03-08T22:21:45.000Z","date":"2017-03-06","kind":"grant","acquired":true,"shares":19490,"price":38.43,"value":749000.7,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"Grant to reporting person of right to buy shares of common stock exercisable in annual increments of 25 percent beginning on the first anniversary of the date of grant."}],"balance_after":19490,"derivative":{"exercise_price":38.43,"exercise_date":"2018-03-06","expiration_date":"2024-03-06","underlying":"Common Stock","underlying_shares":19490},"source":{"system":"sec-edgar","filing":"0001127602-17-010886","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/313143/000112760217010886/form4.xml","form_type":"4"}},{"id":4396166,"issuer":{"id":3953,"kind":"organization","name":"HAEMONETICS CORP"},"owners":[{"id":46227,"kind":"person","name":"Basil Michelle L","position":1,"cik":"0001699629","reported_name":"Basil Michelle L","relationship":{"officer":true,"officer_title":"EVP and General Counsel"}}],"security":"Common Stock","published_at":"2017-03-08T22:21:45.000Z","date":"2017-03-06","kind":"grant","acquired":true,"shares":4879,"price":38.43,"value":187499.97,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Restricted Stock Unit Grant which vest 25% per year over 4 years following the grant date. Grant was made under 2005 Long Term Incentive Compensation Plan."}],"balance_after":4879,"source":{"system":"sec-edgar","filing":"0001127602-17-010886","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/313143/000112760217010886/form4.xml","form_type":"4"}}]}